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When some great sorrow, like a mighty river, 
Flows through your life with peace-destroying power 
And dearest things are swept from sight forever, 
Say to your heart each trying hour: 
"This, too, shall pass away." 
 
When fortune smiles, and, full of mirth and pleasure, 
The days are flitting by without a care, 
Lest you should rest with only earthly treasure, 
Let these few words their fullest import bear: 
"This, too, shall pass away." 
 
When earnest labor brings you fame and glory, 
And all earth's noblest ones upon you smile, 
Remember that life's longest, grandest story 
Fills but a moment in earth's little while: 
"This, too, shall pass away." 
 
 By Lanta Wilson Smith 
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Summary │ 1 
Summary 
 
Haploinsufficiency of the Lis1 gene in human causes type I lissencephaly owing to a 
migration defect of cortical neurons during prenatal brain development. 
Homozygous Lis1 mouse mutants are embryonic lethal, while male mice 
homozygous for a specific gene trap integration in the Lis1 locus are infertile and 
display oligozoospermia. These mutations indicate the essential role of Lis1 in 
different cells, although biochemical mechanisms are not clear.  
 
In a yeast two-hybrid search for Lis1 interaction partners in mouse testis, I isolated 
three novel potential Lis1-binding proteins, Ranbp9 (Ran binding protein 9), ACT 
(activator of CREM in testis), and BRAP (BRCA1 associated protein) in addition to 
the already known binding partner NudeL. GST-pull-down assays, 
coimmunoprecipitations, and reconstitution of split YFP fluorescence in transfected 
HeLa cells confirmed these interactions.  
 
Complex formation of Lis1 and Ranbp9 involves the Lis1 WD-40 repeats and the 
SPRY domain of Ranbp9. ACT binds to Lis1 via the four LIM domains, and BRAP 
interacts with Lis1 through the coiled-coil domain.  
 
In mouse embryonic fibroblasts (MEFs) with genetically reduced levels of Lis1, 
Ranbp9 appears reduced at the cell periphery relative to the central, perinuclear 
region suggesting that Lis1 may play a role in stabilization and/or subcellular 
localization of Ranbp9. Lis1 forms complexes with ACT in the cytoplasm of 
spermatogenic cells in testis suggesting that both, Lis1 and ACT may have functions 
in overlapping processes during late spermatogenesis. BRAP protein also colocalizes 
with Lis1 in the cytoplasm of HeLa cells where it accumulates close to the nucleus.  
 
Furthermore, Lis1 is a microtubule associated protein that influences microtubule 
dynamics by affecting microtubule plus-end stability and the frequency of 
catastrophic breakdown. Analysis of microtubules and plus-end binding proteins in 
Lis1 deficient-MEF cells revealed reduced levels of acetylated tubulin and increased 
decoration of microtubule plus-ends by CLIP-115. Moreover, Lis1 affects the velocity 
of microtubular growth as demonstrated by live cell imaging. These results provide 
further evidence for an essential role of Lis1 in the regulation of microtubule 
dynamics. 
   
Zusammenfassung  
Zusammenfassung 
 
Die Haploinsuffizienz des Lis1 führt beim Menschen zu der Lissenzephalie Typ 1, 
die durch Migrationsdefekte von kortikalen Neuronen während der pränatalen 
Hirnentwicklung verursacht wird. Mausmutanten mit homozygotem Lis1 sind 
vorgeburtlich letal, und männliche Mäuse mit einer Genfalle (gene trap) im Lis1 
Lokus sind infertil und zeigen eine deutlich verringerte Spermienzahl 
(Oligozoospermia). Obwohl die biochemischen Mechanismen unbekannt sind, 
verdeutlichen diese Mutationen die tragende Bedeutung von Lis1 in 
unterschiedlichen Zellen. 
 
Mit einem Yeast-Two-Hybrid System, bei dem mit Lis1 nach interagierenden 
Genen des Mäusehodens geforscht wurde, konnten - neben der Detektion des 
bereits bekannten NudeL - drei neue potentielle Interaktionspartner isoliert 
werden: Ranbp9 (Ran binding protein 9), ACT (activator of CREM in testis) und 
BRAP (BRCA1 associated protein). Darüber hinaus wurde die Interaktion mit Lis1 
durch die Glutathione S-transferase Methode, Koimmunoprezipitation sowie der 
Markierung mit fluoreszierendem YFP in transfizierten HeLa-Zellen verifiziert.  
 
Die Komplexbildung zwischen Lis1 und Ranbp9 wird durch WD-40 Domänen in 
der Lis1-Sequenz sowie durch die SPRY Domäne in Ranbp9 ermöglicht. Die 
Bindung zwischen ACT und Lis1 wird über vier LIM Domänen und die Interaktion 
mit BRAP über eine coiled-coil Domäne induziert. 
 
In embryonalen Mäusefibroblasten (MEFs) mit genetisch reduzierter Lis1 
Expression erscheint die Lokalisation des Ranbp9 an der Zellperipherie 
schwächer, im Vergleich zur zentralen perinuklearen Region. Dies deutet auf 
eine stabilisierende Wirkung hin und/oder eine subzelluläre Lokalisation des 
Ranbp9 durch Lis1. Mit Act bildet Lis1 Protein-Protein-Komplexe im Zytoplasma 
von spermatogenen Zellen des Testikels. 
 
Lis1 formt mit ACT Proteinkomplexe im Zytoplasma von ungereiften Spermien 
(spermatogenic cells) des Hodens. Dies deutet darauf hin, daß Lis1 und BRAP 
während der späten Spermatogenese an sich überschneidenden Prozessen 
beteiligt sind. Außerdem befinden sich BRAP und Lis1 kolokalisiert im 
Zytoplasma von Hela-Zellen, akkumuliert an der Peripherie des Zellkerns.  
   
Zusammenfassung  
Zusätzlich interagiert Lis1 mit Mikrotubuli und beeinflußt den Auf- und Abbau 
der Proteinfilamente durch Einwirkung auf die Stabilität am Plus-Ende und auf 
die Frequenz des Abbaus am Minusende. In Lis1 defizienten Mäusefibroblasten 
(MEFs) konnte die Analyse von Mikrotubuli und Mikrotubulus assoziierten 
Proteinen reduzierte Mengen an acetyliertem Tubulin und eine erhöhte Zahl an 
Mikrotubulus Plus-Ende assoziierter CLIP-115 aufdecken. Darüber hinaus 
beeinflußt Lis1 die Geschwindigkeit des filamentösen Wachstums, wie durch “Live 
Cell Imaging” demonstriert werden konnte. Diese Ergebnisse untermauern 
zusätzlich die Evidenz, daß Lis1 eine essentielle Funktion bei der Regulation der 
Mikrotubulidynamik einnimmt.  
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1. Introduction 
 
Development of the human cerebral cortex is a highly dynamic process which 
involves migration of neuronal progenitor cells leading to the formation of six 
distinct cortical layers. Impaired neuronal migration results in cortical layering 
defects, a smooth brain surface, and abnormal behavior in humans.  
 
Type I (or classical) lissencephaly is a classical example of a severe developmental 
disorder of the human brain characterized by a smooth surface of the cortex and 
abnormal neuronal migration during early stages of brain development (Dobyns, 
1989; Reiner et al., 1993). Most apparent is the nearly complete absence of gyri, 
wide ventricles, and heterotopic neuronal cells (Stewart et al., 1975) (Fig. 1). 
Patients with type I lissencephaly show severe mental retardation, epileptic seizures, 
and a short lifespan (reviewed in Wynshaw-Boris, 2007). 
 
In humans Lis1 was the first gene shown to be genetically linked to type I 
lissencephaly suggesting its causal role for the severe brain malformations (Reiner 
et al., 1993). Haploinsufficiency of Lis1 leads to abnormal cortical layers caused by 
defects in proliferation and migration of neurons in the developing brain (Reiner et 
al., 1993; Hattori et al., 1994; Lo Nigro et al. 1997). Homozygous Lis1 mutant mice 
(Lis1-/-) show early embryonic lethality. In contrast, heterozygous mutant mice 
(Lis1+/KO) are viable and resemble the human disease by displaying abnormal 
organization of layered structures in the central nervous system (CNS) including the 
cortex, the hippocampus, and the olfactory bulb. All these defects in different brain 
regions are attributable to neuronal migration defects during early development of 
the CNS (Hirotsune et al., 1998; Gambello et al., 2003). Additionally, RNA 
interference studies using Lis1 shRNA indicated that the knockdown of Lis1 leads to 
complete arrest of cell proliferation, migration, and morphogenesis during 
neurogenesis (Tsai et al., 2005).  
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Normal human brain Classical lissencephaly
I
II
III
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V
VI
A                                                   B
I
II
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Figure 1. Patients with Lissencephaly have impaired cortical layering. 
A. Normal cortical lamination with 6 layers. Layer I: a superficial layer or molecular layer containing 
mainly extensions of apical dendritic from pyramidal neurons, horizontally-oriented axons, and glial cells. 
Layer II: consists of pyramidal neurons and satellite neurons. Layer III: contains mainly medium sized 
pyramidal neurons Layer IV: contains pyramidal neurons and stellate neurons Layer V: consists of the 
largest pyramidal neurons such as the Betz cells Layer VI: contains large pyramidal neurons and 
multiform neurons, and spindle shaped pyramidal neurons. 
B. Abnormal Cortical layers in type I lissencephaly. Layer I: a superficial layer Layer II: a thin layer 
dominated by neurons as well as some mislocated cells which are normally located in layers I and II. 
Neurons are normally located layers IV-VI in normal brain. Layer III: A thin ribbon of white matter Layer 
IV: a wide layer with heterotopic cells (Stewart et al., 1975) (Adapted and modified from Kerjan and 
Gleeson, 2007; Guerrini and Parrini, 2009) 
 
 
The Lis1 gene is evolutionary conserved and homologues can be found in 
invertebrates like Drosophila melanogaster (termed DLis1; Liu et al., 2000), 
Caenorhabditis elegans (lis-1; Dawe et al., 2001), the fungus Aspergillus nidulans 
(nuclear distribution defective (Nud) F; Xiang et al., 1995), and in the yeast 
Saccharomyces cerevisiae, where the mammalian Lis1 homologue is termed Pac1 
(perish in the absence of CIN8; Geier et al., 1997).  
 
Lis1 is a microtubule-associated protein (Sapir et al., 1997). Microtubules are 
dynamic structures of the cytoskeleton with essential functions in cell division, cell 
migration, and vesicular transport. Microtubules consist of polymerized 
heterodimers of - and -tubulin. Both subunits are highly conserved in all 
eukaryotes. Interestingly, recent data suggest that perturbation of cortical 
lamination may also result from mutations in - or - tubulin in humans. Since 
TUBA1 mutant mice also display abnormal laminar architecture of hippocampus and 
cortex due to impaired neuronal migration (Keays et al., 2007; Jaglin et al., 2009). 
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Lack of -tubulin reduces GTP binding and disrupts heterodimer formation of 
tubulin suggesting that defects of microtubular function are the cause of abnormal 
neuronal migration (Keays et al., 2007). Mutations in the -tubulin gene TUBB2B 
also lead to defects in cortical development resulting in asymmetrical 
polymicrogyria resembling lissencephaly, including the reduction of gyri and a thick 
disorganized cortical plate with abnormal lamination (Jaglin et al., 2009). RNAi-
based TUBB2B inactivation experiments demonstrated that -tubulin is essential for 
neuronal migration (Jaglin et al., 2009). In summary, these data suggest that 
microtubule-based processes are very important for proper development of the 
mammalian brain. 
 
Mammalian Lis1 mRNA and protein are ubiquitously expressed in all tissues. 
However, tissue-specific variations of mRNA splicing and polyadenylation are known 
in adult brain (5.4kb mRNA), heart (4.4kb mRNA), and testis (2.4kb mRNA) 
(Peterfy et al., 1998). Especially in testis, an alternatively spliced transcript 
containing an additional exon 2a was found in the 5’-untranslated region. It is 
interesting to note, however, that the Lis1 protein encoded by probably all splice 
isoforms remains unchanged by the alternative splicing events.  
 
 
 
LisH         Coiled coil                7WD-40 repeats
1  6                  39 40                85 96                410
 
 
Figure 2. Schematic illustration of the Lis1 protein structure 
Full length Lis1 consists of 410 amino acids and contains three main domains. A LisH domain (aa 6-39) 
located at the N-terminus followed by a Coiled coil domain (aa 40-85), and, at the C-terminus of Lis1, 
the 7WD-40 repeat domains (aa 96-410) are formed. 
 
 
 
The Lis1 gene codes for a cytoplasmic protein of 45kDa consisting of 410 amino 
acids. The protein contains three known structural motifs. The Lis1-homology (LisH) 
motif is located at the N-terminus of Lis1 (aa 6-39) and has also been found in 
many other eukaryotic proteins. This region may mediate dimerization and has 
been implicated in regulating neuronal migration and microtubular dynamics (Emes 
   
Introduction │ 5 
and Ponting, 2001). An alpha-helical region (aa 40-85) consisting of a coiled-coil 
domain is located distal to the LisH motif and may mediate important protein-
protein interactions (Burkhard et al, 2001; Mason and Arndt, 2004). The N-
terminus including the LisH motif together with the coiled-coil domain (aa 1-95) is 
known to be responsible for the homodimerization of Lis1 protein that is an 
essential subunit in the platelet activating factor-acethylhydrolase (PAF-AH) 
complex (Cahana et al., 2001; Kim et al., 2004). A heterozygous N-terminal 
deletion of Lis1 in mouse results in aberrant morphology of cortical neurons and 
radial glia in the developing cortex owing to retardation of neuronal migration. This 
emphasizes once again the importance of the N-terminus of the Lis1 protein 
(Cahana et al., 2001).  
 
The carboxy-terminus of Lis1 is composed of 7 WD-40 repeat motifs (aa 96-410). 
Each of these conserved elements contains around 40 amino acids, often initiated 
by glycine-histidine (GH), and terminated by tryptophan-aspartic acid residues 
(WD) (Kim et al., 2004; Li and Roberts, 2001). WD repeat proteins may form a 
beta-propeller structure which is thought to mediate protein-protein interactions, 
but may also to be involved in signal transduction, assembly of the cytoskeleton, 
regulation of vesicular trafficking, cell cycle regulation, and apoptosis (reviewed in 
Li and Roberts, 2001).  
 
 
Lis1 functions in two distinct biological pathways. First, Lis1 is part of the Type I 
platelet activating factor-acethylhydrolase (PAF-AH) complex in which it constitutes 
the noncatalytic beta subunit (PAF-AH1b) (Reiner et al., 1993; Hattori et al., 1994), 
besides the two catalytic subunits, 1 and 2 (Arai et al., 2002).  All subunits of 
PAF-AH are highly expressed in the developing brain and testis suggesting a role 
during neuronal development and spermatogenesis (Koizumi et al., 2003). PAF-AH 
inactivates platelet activating factor (PAF) by hydrolyzing the acetyl group that is 
required for the biological function of PAF (Arai et al., 2002). PAF is a potent 
phospholipid activator present in various organs, particularly in the brain and the 
reproductive organs. It participates in fundamental physiological processes such as 
inflammation and vascular permeability (Hattori et al., 1994; Tjoelker et al., 1995; 
Brkovic and Sirois, 2007). In addition, PAF is essential for sperm motility and 
acrosomal function, although it seems to be dispensable for sperm development 
(Roudebush, 2001; Angle et al., 1993). PAF has been implicated also in pathological 
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processes in the CNS, such as stroke and ischemia (Hattori et al., 1994; Palmer et 
al., 1997; Umemura et al., 2007). Second, Lis1 participates in the regulation of 
microtubular dynamics. For this role, Lis1 binds to the plus-ends of microtubules 
besides interacting with several other proteins, such as cytoplasmic dynein, 
dynactin, and CLIP-170.  
 
Lis1 directly interacts with the cytoplasmic dynein-dynactin motor complex which 
requires ATP as the energy source for cargo transport towards the minus-end of 
microtubules and is essential for various cellular processes including transport of 
vesicles and organelles, Golgi dynamics, and mitosis (Holzbaur and Vallee, 1994; 
Hirokawa, 1998; Ahmad et al., 1998). Lis1 has been suggested to be involved in 
the regulation of the ATPase activity of dynein whereby it may influence motor 
activity and consequently cargo transport along microtubules (Mesngon et al., 
2006). In addition, Lis1 and the cytoplasmic dynein-dynactin complex appears to 
colocalize at the cell cortex and at mitotic kinetochores indicating that Lis1 may also 
influence the subcellular localization of cytoplasmic dynein and dynactin as well as 
mitotic progression and spindle orientation (Siller et al., 2005; Faulkner et al., 
2000). Supporting this view, overexpression of Lis1 in cultured cells leads to 
increased retrograde movement of cytoplasmic dynein and accumulation of 
microtubules at the cell periphery (Smith et al., 2000). In summary, Lis1 is thought 
to regulate cytoplasmic dynein-driven retrograde movements along microtubules as 
well as neuronal migration and axon growth.  
 
NudF, the fungal Lis1 homologue, has been identified as a gene required for 
dynein-mediated nuclear migration along microtubules indicating that Lis1 plays a 
role in nucleokinesis in Aspergillus nidulans (Xiang et al., 1995). In Aspergillus, 
NudF genetically interacts with the microtubule motor machinery including NudA 
and NudG, representing the homologues of dynein heavy and light chains, 
respectively. Other genes such as NudE and NudC are also required for nuclear 
migration (Efimov and Morris, 2000). NudE was originally identified as a multicopy 
suppressor of NudF. It has two known mammalian homologues, mouse NudE 
homolog (NudE) and NudE-like (NudeL) which were identified as Lis1 interacting 
proteins in yeast two-hybrid screens (Feng et al., 2000; Niethammer et al., 2000; 
Sasaki et al., 2000; Efimov and Morris, 2000). NudE and NudeL are related proteins 
that both accumulate at the centrosome where they colocalize with Lis1 (Feng et al., 
2001; Sasaki et al., 2005). Inhibition of NudE and NudeL leads to metaphase arrest 
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suggesting that both proteins, together with Lis1, are required for mitotic 
progression (Stehman et al., 2007). Homozygous NudeL knockout mice show early 
embryonic lethality, similar to the homozygous Lis1 mutant, whereas viable 
hypomorphic NudeL mutants exhibit mild defects in neuronal migration. Lis1 and 
NudeL double mutant mice, heterozygous for each allele, display more severe 
neuronal migration defects suggesting that both genes interact genetically (Sasaki 
et al., 2005). Interestingly, Lis1 and NudeL simultaneously interact with cytoplasmic 
dynein and regulate the distribution of cytoplasmic dynein along microtubules 
(Sasaki et al., 2000; Stehman et al., 2007).  
 
Lis1 associates with microtubules and it has been implicated in the regulation of 
microtubule dynamics by preventing microtubule catastrophe events (Sapir et al., 
1997). Moreover, different cellular levels of Lis1 affect the distribution of 
microtubules again suggesting that Lis1 contributes to the regulation of 
microtubular stability (Smith et al., 2000; Yingling et al., 2008). Lis1 and several 
proteins specifically bind to the growing plus-ends of microtubules (so called +TIP 
binding proteins). For instance, the cytoplasmic linker proteins-170 (CLIP-170) was 
the first identified +TIP binding protein that has been suggested as a regulator of 
microtubules (Pierre et al., 1992; Binker et al., 2007). CLIP-170 has been shown to 
associate with p150glued, a central component of the dynactin complex as well as 
Lis1 (Lansbergen et al., 2004). Hence Lis1 might regulate the interactions between 
the dynein-dynactin complex and CLIP-170 for microtubule dynamics (Coquelle et 
al., 2002; Tai et al., 2002). Furthermore, p150glued competes with Lis1 for binding to 
CLIP-170 (Lansbergen et al., 2004). These observations suggest that Lis1 
contributes to a complex network of protein-protein interactions required for the 
regulation of microtubular stability and dynein motor function at the plus-end of 
microtubules. (Smith et al., 2000; Lansbergen et al., 2004). The precise molecular 
organization of Lis1 and other +TIP binding proteins is unclear.  
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Homozygous Lis1 gene trap mutant male mice (Lis1GT/GT) with a selective disruption 
in a testis specific Lis1 transcript show severe defects in spermatogenesis indicating 
that Lis1 plays an important role during germ cell development (Nayernia et al., 
2003).  
 
Spermatogenesis is the developmental process of the generation of male germ cells 
in the testis. In general, spermatogenesis starts from spermatogonial cells which 
reside in the basal layer of the germinal epithelium of the testis. Spermatogonia 
can divide mitotically and by this process maintain the population of spermatogonial 
cells. However, these cells also produce primary spermatocytes which are able to 
initiate the first meiotic division and yield secondary spermatocytes. These cells 
subsequently enter the second meiotic division to produce haploid spermatids. The 
differentiation of spermatids into mature sperm cells is termed spermiogenesis and 
corresponds to the final process of spermatogenesis. Not only nuclear condensation 
and acrosomal formation but also flagellum formation and a significant reduction of 
cytoplasm all take place during this final stage of spermatogenesis. Although Lis1 is 
highly expressed in testis, its specific function during spermatogenesis remains 
unknown.  
 
 
Figure 3. Schematic illustration of cross-section of a mouse seminiferous tubule 
The epithelium consists of Sertoli cells and the spermatogenic cells. Spermatogenic cells are in close 
contact with sertoli cells which support and nourish spermatogenic cells as well as secrete hormones, 
and phagocytize cell debris. The spermatogonial cells are located in the basal lamina of the seminiferous 
tubules and spermatogenic cells are migrated toward the lumen. (Adapted from Gilbert et al., 2003) 
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All subtypes of the Type I platelet-activating factor acethylhydrolase (PAF-AH) are 
enriched in testes. 2 and Lis1, both are detected in the cytoplasm of all types of 
spermatogenetic cells enriched in mitotic spermatocytes and elongated spermatids 
(Koizumi et al., 2003; Nayernia et al., 2003; Yan et al., 2003). In contrast, 1 is 
restricted to the basal region of seminiferous tubules particularly in the cytoplasm 
of spermatogonial cells suggesting that this protein might be involved in the 
proliferation and differentiation of spermatogonia (Koizumi et al., 2003; Yan et al., 
2003).  
 
While 1-/- mutant mice are fertile with no apparent phenotype, 2-/-mutant males 
are infertile due to severe defects in spermatogenesis. 1-/-2-/-double-mutants 
show early defects in spermatogenesis with increased apoptosis in the seminiferous 
tubule and degeneration at spermatocytes stages suggesting that the catalytic 
subunits (1 and 2), particularly 2, are important for male germ cell 
differentiation (Yan et al., 2003; Koizumi et al., 2003). Up-regulated Lis1 was 
detected in either 2-/- or 1-/-2-/- mutant mice. Interestingly, the drastic testis 
specific phenotypes of 2-/- or 1-/-2-/- knockout mice can be rescued by reduced 
Lis1 levels suggesting important doses affect of components of PAFAH1B complex 
during spermatogenesis (Yan et al., 2003).  
 
Microtubules are dramatically rearranged during spermatogenesis, a process that 
requires mitotic division of spermatogonia, meiotic division of spermatocytes, 
manchette formation, and flagella axoneme assembly in spermatids (Koizumi et al., 
2003). Lis1 associates with microtubules via microtubule binding proteins, such as 
dynein (Tai et al., 2002). Lis1 in spermatids indeed colocalizes with -tubulin and 
dynein (Nayernia et al., 2003). Lis1 has also been shown to associate with the Golgi 
complex, the distribution of which is affected by different levels of Lis1 (Nayernia et 
al., 2003; Smith et al., 2000). This supports the idea that Lis1 may play a role in 
vesicular transport mediated by dynein motor function during spermiogenesis. 
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1. 1. Aim of this study 
 
Mutations in the Lis1 gene are known to cause severe developmental defects, such 
as type I lissencephaly and oligozoospermia (Reiner et al., 1993; Nayernia et al., 
2003). However the precise molecular functions of Lis1 for spermatogenesis are not 
understood. 
 
To get better insights into the role of Lis1 in general and in spermatogenesis in 
particular, I here present experiments that were designed to identify novel binding 
partners of Lis1 in testis, confirm their mode of interaction, and examine 
consequences of Lis1 gene disruption.  
 
I discovered 3 novel Lis1 interaction partners. One of which is testis-specific, the 
other two are ubiquitously expressed. The formation of complexes between these 
proteins and Lis1 were confirmed in vitro and in vivo.  
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2. Materials and Methods 
 
2. 1. Materials 
 
2. 1. 1. Chemicals, reagents, and solutions 
 
All chemicals and regents were bought from Roth, Merck, Sigma, Promega, Roche, 
and Fluka. Standard solutions and buffers used in this study were prepared as 
described in Sambrook et al. (1989). 
 
2. 1. 2. Kits 
 
Kits Company Cat# 
Qiagen plasmid mini kit Qiagen 12123 
Qiagen plasmid midi kit Qiagen 12243 
Qiagen plasmid maxi kit Qiagen 12263 
MinElute reaction cleanup kit Qiagen 28204 
MinElute gel extraction kit Qiagen 28604 
 
2. 1. 3. Enzymes 
 
Restriction enzymes and supplied buffers used in this study were purchased from 
New England Biolabs.  
 
Enzymes   
DNAse Promega M-6101 
Proteinase K Roth 7528.2 
DNA polymerase I large (Klenow) fragment Promega M-2201 
Taq DNA polymerase TaKaRa R001A 
Ex Taq DNA polymerase TaKaRa R006A 
Pfu DNA polymerase Promega M-7741 
T4 DNA ligase Promega M-1801 
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2. 1. 4. Oligonucleotides 
 
Oligonucleotides served as primers (1) for RT-PCR to detect the mRNA expression 
of certain genes, (2) for sequencing to confirm the complete open reading frame, 
and (3) for genotyping of Lis1 mutant mouse lines and derived murine embryonic 
fibroblast (MEF) lines, and (4) to amplify DNA fragments for subcloning. 
 
 
Primers for RT-PCR: 
Name Sequence 5’ to 3’ 
Lis1-5’ GTGGTCATAGGAGTCCAGTTACTC 
Lis1-3’ CCATACGTACCCATTCTCTGTGTC 
Ranbp9-5’ CTTCTGGAACTGGACAACCGTATG 
Ranbp9-3’ GAACAGTCTGGTCTGTAGATCTGG 
ACT-5’ CTTCATCCGCTGCTCTACAA 
ACT-3’ CCTGGCATGATGGTTCTCTT 
BRAP-5’ CCTGCCAGGAAGAGAAGATAGATG 
BRAP-3’ CTGTGTCTCCAGGTAGAACATGAC 
GAPDH-5’ ATCCCATCACCATCTTCCAG 
GAPDH-3’ CCTGCTTCACCACCTTCTTG 
 
 
Primers for sequencing: 
Name Sequence 5’ to 3’ 
GAL4 DBD-5’ GTGCGACATCATCATCGGAAG 
GAL4 AD-5’ AAT ACC ACT ACA ATG GAT GAT 
GAL4 AD-3’ GTGAACTTGCGGGGTTTTTCA 
pGEX-5’ GGGCTGGCAAGCCACGTTTGGTG 
pGEX-3’ CCGGGAGCTGCATGTGTCAGAGG 
T7 TAATACGACTCACTATAGGG 
BGH#1-3’ CAACTAGAAGGCACAGTCGAGGCTG 
CRE-3' (160-177) CCTCATCACTCGTTGCAT 
CYFP#1-5’ TCCGCCCTGAGCAAAGAC C 
Venus-2-5’ AGTCCGCCCTGAGCAAAGAC 
pEGFP-C2-3’ TTTCAGGTTCAGGGGGAGGTG 
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Name Sequence 5’ to 3’ 
pRNA-U6-5’ TACGATACAAGGCTGTTAGAGAG 
Cherry#4-5’ GAAGTTGGACATCACCTCCCAC 
Cheery#5-5’ ACGGCGAGTTCATCTACAAGGT 
Cherry#6-3’ ACCTTGTAGATGAACTCGCCGT 
 
 
Primers for genotyping: 
Name Sequence 5’ to 3’ 
Lis1-I3-sense ATGGTGCATGTGTGAGTATCTGC 
Lis1-I7-sense TGAATGCATCAGAACCATGC 
Lis1-I7-antisense CCTCTACCACTAAAGCTTGTTC 
 
 
Primers for cloning: 
Construct Name Sequence 5’ to 3’ 
pDBD-GAL4-Lis1 Lis1-EcoRI-5’ GAATTCATGGTGCTGTCCCAGAGACAACGAATGAAC 
pDBD-GAL4-Lis1 Lis1-SalI-3’ GTCGACTCAATCAACGGCACTCCCACACC 
HA-SPRY Ranbp9-SPRY 5’ GAATTCCTCAACGAGCAGGAGAAGGAG 
HA-SPRY 
Ranbp9#7 AS-
EcoRI+STOP 
TGAGGAATTCTCATCCTTCTCGATCCCCGATAGG 
HA-LisH+CTLH 
HA-Ranbp9-
LisH/CTLH-5'-XhoI 
CTCGAGATGGACCGCTTTCCTATCGGGGATCGAGAAGGA 
HA-LisH+CTLH 
HA-Ranbp9-
LisH/CTLH-3'-
HindIII 
AAGCTTCTACAAACACCGCACTTCACTGTCTGTACCATT 
HA-ACT-F ACT-EcoRI-5’ GAATTCATGACAAGTAGTC 
HA-ACT-F ACT-BamHI-3’ GGATCCTTTCTAAGCGTCA 
HA-LIM4 
HA-ACT-LIM4-5'-
EcoRI 
GAATTCATGGCTAAAAAGTGTGCAGCCTGCACCAAACCC 
HA-LIM4 
HA-ACT-LIM4-3'-
BamHI 
GGATCCTTTCTAAGCGTCAGTGTCTGCCCCGGACGGACA 
HA-BRAP-F BRAP#1-5’ AGATCTCGAGATGGCGTGCAATGGCCGCCAGTT C 
HA-BRAP-F BRAP#2-3’ TAGATAAGCTTGGATGGTCACTTGCCCCTCTTGCTGC 
Venus-N-BRAP BRAP#3-5’-EcoRI TAGATGAATTCATGGCGTGCAATGGCCGCCA 
Venus-C-BRAP & 
Venus-C-cBRAP 
BRAP#5-3’-SalI TATATGTCGACTCACTTGCCCCTCTTGCTGC 
Venus-N-cBRAP BRAP#4-5’-EcoRI TAGATGAATTCGCCTTACAGTTAGAGTACTCGTACCTG 
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Oligo nucleotides serving as DNA linker fragments: 
Construct Name Sequence 5’ to 3’ 
pGEX-4T-1-Lis1-C pGEX-4T-1-Lis1-C GATCCCCGTCGAC 
Venus-N-Ranbp9 &  
Venus-C-Ranbp9 
Venus/ pEGFP-Linker (SalI)-5’ TCGAATGGAGC 
Venus-N-Ranbp9 &  
Venus-C-Ranbp9 
Venus/ pEGFP-Linker (SalI)-3’ TCGAGCTCCAT 
HA-CRE CRE-Linker (EcoRI)-5' GTACGAATTCG 
HA-CRE CRE-Linker (EcoRI)-3' GTACCGAATTC 
 
 
2. 1. 5. Antibodies 
 
For Western blot analysis, immunocyto-, or immunohistochemistry several 
antibodies were used. 
 
2. 1. 5. 1. Primary antibodies 
 
Primary antibodies   Dilution 
Mouse monoclonal IgG Anti-Lis1 (N-19) Santa Cruz sc-7577 
WB 1:2000 
IC 1:250 
Goat polyclonal IgG Anti-Lis1 (G-3) Santa Cruz sc-17817 
WB 1:2000 
IC 1:250 
Goat Anti-ACT (K-18) Santa Cruz sc-9368 IC 1:100 
Anti-GST Amersham Biosciences 27-4577-01 WB 1:5000 
HA11 Monoclonal Antibody Covance MMS-101R 
WB 1:2000 
IC 1:250 
Goat Anti-RanbpM/Ranbp9 ImgeneX IMX-3686 
IC 1:100-250 
IH 1:100 
Rabbit Anti-Gamma tubulin Sigma T5192 
WB 1:5000 
IC 1:500 
Anti-FLAG BioM2 Sigma F9291 WB 1:2000 
Anti-FLAG M2 Monoclonal Antibody Sigma F3165 
WB 1:2000 
IC 1:250 
Monoclonal Anti-Lis1 Clone Lis1-338 Sigma L7391 WB 1:2000 
Anti-EB1 BD 610535 
WB 1:2000 
IC 1:500 
Anti-p150glued BD 610474 
WB 1:1000 
IC 1:200 
 
WB (Western Blot), IC (Immunocytochemistry) 
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2. 1. 5. 2. Secondary antibodies 
 
Secondary antibodies   Dilution 
Anti-Goat IgG peroxidase conjugate Sigma A5420 WB 1:8000 
Streptavidin-Peroxidase Streptomyces avidinii Sigma S5512 WB 1:2000 
Anti-mouse IgG (Cy3) Sigma C2181 
IC 1:250 
IH 1:250 
Anti-Rabbit peroxidase conjugate Amersham Biosciences NIF 824 WB 1:2000 
Anti-mouse IgG+IgM peroxidase conjugate Jackson ImmunoResearch 115-035-068 WB 1:8000 
Anti-mouse IgM (DyLight 549) Jackson ImmunoResearch 715-505-140 IC 1:250 
Anti-mouse IgG (Cy2) Jackson ImmunoResearch 715-225-150 IC 1:250 
Anti-Rat IgG (Cy3) Jackson ImmunoResearch 712-165-150 IC 1:250 
Anti-Rabbit IgG (Cy5) Jackson ImmunoResearch 711-175-152 IC 1:250 
Anti-Goat IgG (Cy3) Jackson ImmunoResearch 705-165-147 IC 1:250 
Anti-mouse IgG+IgM peroxidase conjugate Jackson ImmunoResearch 115-035-068 WB 1:8000 
Anti-mouse igG (H+L) peroxidase conjugate Dianova 115-035-062 WB 1:8000 
Anti-rabbit igG (H+L) peroxidase conjugate Dianova 111-035-045 WB 1:2000 
Anti-rat igG (H+L) peroxidase conjugate Dianova 112-035-062 WB 1:2000 
Anti-mouse IgG (H+L) Alexa Fluor 594 
Invitrogen  
(molecular probes) 
A11032 IC 1:200 
Anti-Rabbit IgG (H+L) Alexa Fluor 594 
Invitrogen  
(molecular probes) 
A11037 IC 1:250 
Anti-Rat IgG (H+L) Alexa Fluor 594 
Invitrogen  
(molecular probes) 
A11007 IC 1:200 
 
WB (Western Blot), IC (Immunocytochemistry) 
 
2. 1. 6. Yeast strains 
 
The GAL4 based yeast two-hybrid screening as well as corresponding 
cotransformation assays were performed using the AH109 yeast strain. Alternatively, 
the L40 yeast strain was used for interaction studies involving the LexA based 
system.    
 
Yeast strain Promoter  Reporter genes Genotype Reference 
AH109 GAL4  ADE2/ HIS3/ LacZ 
MATa trp1 leu2 ura3 his3 
Gal4Δ,gal80Δ,LYS:: 
GAL1UAS-GAL1TATA-HIS3 
GAL2UAS-GAL2TATA-ADE2 
URA3::MEL1UAS-MEL1TATA-lacZ 
James et al., 
1996 
A. Holtz, 
unpublished 
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Yeast strain Promoter  Reporter genes Genotype Reference 
L40 LexA HIS3/ LacZ 
MATa trp1 his3 leu2 ade2 
LYS2::lexAop (4x)-His3 
URA::lexAop (8x)-lacZ 
Vojtek, 1993 
 
2. 1. 7. Bacterial strains 
 
For cloning purposes, the E. coli strain XL1-blue was used. The E. coli strain BL21 
strain was used for expression of recombinant proteins. 
 
Ecoli strain Genotype Purpose Reference 
XL1-blue 
recA1, endA1, gyrA96, thi-1, hsdR17, supE44v, 
rela1,lac-[F’,proAB, lacIqZΔM15,Tn10(Tetr)] 
Cloning 
Bullock et al., 
1987 
BL21 F- ompT gal dcm lon hsdSB (rB
- mB
-) Protein expression 
Studier et al., 
1990 
 
2. 1. 8. Mammalian cell lines 
 
Cells were maintained in Dulbecco’s modified Eagle Medium (DMEM, PAA 
Laboratories) supplemented with 10% fetal calf serum (FCS), 1% 
penicillin/streptomycin, and 1% L-glutamine at 37℃, 10% CO2 and 99% humidity 
incubator. 
 
Mammalian cell lines  Source Reference 
HeLa Human epithelial carcinoma cell line 
Gossen and 
Bujard, 1992 
COS-7 
African Green Monkey SV40-transformed kidney 
fibroblast cell line 
Gluzman, Y. 1981 
HEK293T 
Human embryonic kidney cells transformed with the 
SV40 Large T antigen 
Lebkowski et al., 
1985 
 
2. 1. 9. Mouse strains 
 
Mice strain  Reference 
Lis1wt/flox and Lis1flox/flox 
mutants 
CRE mediated Lis1 gene excision  
Hirotsune et al., 
1998 
 
Mouse strain C57BL/6N was used for preparing wild type testis. 
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2. 2. Methods 
 
2. 2. 1. Molecular biology Methods 
 
2. 2. 1. 1. Plasmid construct 
 
A GAL4-DBD-Lis1 fusion construct was generated to serve as a bait in the yeast 
two-hybrid screen. A full-length Lis1 cDNA clone (accession number #U95116, a 
kind gift of Prof. Eichele) was used to synthesize a Lis1 fragment by PCR with 
primers containing specific restriction sites (Lis1-EcoRI-5’ and Lis1-SalI-3’) and 
inserted into the pGEM-Teasy vector. The Lis1 ORF of this plasmid (termed pGEM-
Teasy-Lis1) was sequenced completely and no differences to the published Lis1 
cDNA were detected. Subsequently, pGEM-Teasy-Lis1 was digested with EcoRI and 
SalI and the Lis1 fragment was ligated into the EcoRI restriction site of the pBD-
GAL4 vector. The resulting pBD-GAL4-Lis1 fusion construct was sequenced at the 
GSL4-Lis1 junctions to confirm its integrity. 
 
2. 2. 1. 2. Preparation of competent cells 
 
A fresh E. coli colony of the strain XL1-blue was incubated in 2ml of LB-Medium 
overnight with shaking at 37℃. 450µl of this preculture was used to inoculate 40ml 
LB-Medium and grown at 37℃ until an OD600 value of 0.3 to 0.5. The culture was 
chilled on ice for 10min and centrifuged at 4000rpm for 10min at 4℃. The bacterial 
pellet was carefully resuspended in 500µl of ice-cold Solution A. An additional 2.5ml 
of ice-cold Solution B was added and mixed gently. The competent cells were stored 
in aliquots at -70℃.  
 
LB-Agar: 
10g NaCl 
10g Trypton 
5g Yeast Extract 
20g Agar 
Add ddH2O up to 1000ml 
Adjust pH 7.0 with 5M NaOH 
Autoclave 
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LB-Medium: 
10g NaCl 
10g Trypton 
5g Yeast Extract 
Add ddH2O up to 1000ml 
Adjust pH 7.0 with 5M NaOH 
Autoclave 
 
Solution A: 
10mM MgSO4 
0.2% Glucose 
Add LB-Medium up to 50ml 
Filtration 
(prepare a fresh Solution A) 
 
Solution B: 
36% Glycerin 
12% PEG 6000 
12mM MgSO4 
Add LB-Medium up to 100ml 
Filtration 
(store at 4℃ for at least several month) 
 
2. 2. 1. 3. Ligation 
 
A standard ligation reaction of linearized vector together with a DNA fragment 
digested with matching restriction enzymes was carried out as follows: 
 
Ligation 
Vector DNA 30ng 
Insert DNA 
1:3 molar ratio of vector DNA to 
insert DNA 
10x ligation buffer 1µ l 
T4 DNA ligase 1µ l 
 
Add dH2O up to 10µ l 
 
Ligation was performed overnight at 16℃. 
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2. 2. 1. 4. Transformation 
 
Competent bacterial cells were thawed on ice and 20-50ng of super-coiled plasmid 
DNA or ligated DNA was added to 100µ l competent cells. This mixture was 
incubated on ice for 30min and the DNA was introduced into the bacterial cells via 
heat-shock for 90s at 42℃. 400µl LB medium lacking antibiotics was added to the 
bacteria and incubated at 37℃ for 30min. 100µ l-250µ l of the bacterial suspension 
was plated on LB-Agar plates containing an appropriate antibiotic allowing selection 
of plasmid containing cells.   
     
2. 2. 1. 5. Purification of plasmid DNA 
 
2. 2. 1. 5. 1. Classical mini preparation 
 
Plasmid DNA was isolated from transformed bacteria by using the mini preparation 
method.  
 
A single colony was picked and inoculated under selection conditions in 2ml LB 
medium overnight at 37℃. The culture then was centrifuged and the pellet was 
resuspended in 100µl GET buffer containing RNase A (100µg/µ l). 200µ l lysis buffer 
(0.2M NaOH and 1% SDS) was added and mixed gently by inverting. 150µl high 
salt buffer was added and mixed gently again. The sample was incubated on ice for 
15min and centrifuged at full speed for 10min. The supernatant was transferred to 
a new tube and centrifuged again at full speed for 10min. The supernatant was 
transferred to a new tube and 900µl isopropanol was added to precipitate the DNA. 
The sample was mixed gently, incubated at room temperature for 15min, and then 
centrifuged at full speed for 10min. The DNA pellet was washed with 70% EtOH, 
air-dried, and resuspended in 30µ l of 1×  TE buffer. 
 
GET buffer: 
50mM Glucose 
10mM EDTA 
25mM Tris-HCl (pH 8.0) 
Add ddH2O up to 500ml 
Filtration and then storage at 4℃ 
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High-Salt buffer: 
3M Potassium acetate 
1.6M Formic acid 
Add ddH2O up to 500ml 
Filtration and then storage at 4℃ 
 
10×  TE buffer: 
1M Tris (pH 8.0) 
0.5M EDTA (pH 8.0) 
Add ddH2O up to 1000ml and then autoclave  
     
2. 2. 1. 5. 2. Classical maxi preparation 
 
To obtain plasmid DNA in large quantities and with high purity, an overnight 
bacterial culture of 300ml was chilled on ice and centrifuged for 15min at 6000rpm 
at 4℃. The pellet was washed with 100ml of dH2O and centrifuged again. The pellet 
was dissolved in 40ml of cold GET-buffer. 80ml freshly prepared 0.2M NaOH/ 1% 
SDS was added and incubated for 5min on ice. 50ml High-Salt-buffer was added, 
mixed gently by inverting, and then incubated again for 15min on ice. The sample 
was centrifuged for 10min at 10.000rpm at 4℃ and the supernatant was filtrated 
through a paper filter. To precipitate plasmid DNA, 90ml isopropanol was added, 
incubated for 15min at room temperature, and centrifuged for 10min at 10.000rpm. 
The plasmid DNA pellet was air-dried and completely dissolved in 5.5ml 1×  TE 
buffer. Caesium chloride (1.1g/ml) and 80µ l ethidiumbromid (10mg/ml) were added 
and transferred to an ultra centrifugation tube which was filled up with Rebanding 
mix. Subsequently the sample was centrifuged for 24hrs at 45.000rpm (Beckman 
L60-ultracentrifuge, rotor 701 Ti) at room temperature. Using appropriate UV 
illumination, the DNA band was isolated and transferred to a fresh ultra 
centrifugation tube for a second centrifugation under the same conditions. Isolated 
plasmid DNA was mixed with an equal amount of isobutanol/ 12% H2O to extract 
the ethidiumbromid out of the solution. The solution was subsequently dialyzed 
against 1×  TE buffer for 3hrs at room temperature and then overnight at 4℃. 3M 
sodium acetate and 2.5 volumes of 96% cold EtOH were added to the solution, 
which was then incubated for 30min on dry ice allowing the DNA to precipitate. The 
sample was centrifuged for 30min at 3.600rpm at 4℃. The DNA pellet was washed 
with 70% cold EtOH, air-dried, and dissolved in 300µ l of dH2O. 
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Rebanding mix: 
333g calcium chloride  
350ml 1x TE buffer 
11.3ml ethidiumbromid (10mg/ml) 
Filtration and then storage at room temperature (dark) 
 
isobutanol/ 12% H2O: 
120ml dH2O 
880ml isobutanol 
 
 
2. 2. 1. 6. Quantification of DNA and RNA 
 
The concentration of nucleic acids was determined by using an UV 
spectrophotometer at a wavelength of 260nm. An absorption of 1 at 260nm 
corresponds to a double stranded DNA concentration of 50µg/ml. The following 
formula was used to calculate the concentration of double stranded DNA:    
 
OD260 x dilution factor x 50µg/ml 
1000µg/ml 
=  x µg/µ l 
 
 
In addition, the concentration of RNA and single stranded DNA also can be 
measured at 260nm. However an absorption of 1 at 260nm corresponds to a RNA 
concentration of 38µg/ml.  
 
 
2. 2. 1. 7. DNA sequencing 
 
The DNA sequencing procedure was used to confirm the integrity of open reading 
frames, to check the junctions of fusion protein cDNA constructs, and to identify 
cDNA clones isolated from the yeast two-hybrid screening. Sequencing reactions 
were performed by using the Big Dye terminator v1.1 cycle sequencing kit (Applied 
Biosystems) and a sequence-specific primer.  
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For 1 reaction 
 
Sequencing condition  
250-500ng dsDNA  2µ l Initial denaturing 94℃ 2min 
Premix(BD) 2µ l Denaturing 94℃ 30sec 
10pmol primer 1µ l Annealing++ x℃ 15sec 
dH2O 5µ l Extension 60℃ 4min 
Total 10µ l Final extension 72℃ 10min 
  Pause 8℃ ∞ 
 
++Annealing temperature is changed depending on a specific primer. 
The cycle of denaturing, annealing and extension was repeated 25 times. 
 
Subsequently, 90µ l dH2O, 10µ l 3M NaAcO (pH 5.5), and 250µl 100% EtOH were 
added to the sequencing reaction. The sample was incubated at room temperature 
for 15min and centrifuged at full speed for 15min. The precipitated DNA pellet was 
washed with 70% EtOH and dried under vacuum. 12.5µl template suppression 
reagent (Applied Biosystems) was added. The sequencing reaction was incubated at 
90℃ for 2min to denature the labeled single stranded DNA which subsequently was 
analyzed on an ABI PRISM310 genetic analyzer (Applied Biosystems).  
 
2. 2. 1. 8. Isolation of genomic DNA 
 
Genomic DNA was isolated from mouse tissues using the phenol/chloroform 
extraction method. Dissected mouse tissues were dissolved in digestion solution at 
55℃ overnight. A Phenol:Chloroform mix (1:1) was added, mixed gently by 
inverting several times, and centrifuged. The aqueous phase containing genomic 
DNA was carefully transferred to a fresh tube with an equal amount of chloroform, 
mixed well, and after centrifugation, was transferred into a fresh tube containing 
isopropanol. Precipitated DNA was collected by centrifugation, washed briefly with 
70% ethanol, air-dried, and completely dissolved in 10mM Tris buffer (pH7.5) either 
at 60℃ for 15min or at 4℃ for overnight. The isolated DNA was used for PCR 
genotyping.  
 
Digestion solution: 
100mM Tris·Cl, pH 8.5 
5mM EDTA 
200mM NaCl 
0.5% Tween 20 
0.2mg/ml Proteinase K (diluted 1:500 from a 100mg/ml Proteinase K stock) 
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2. 2. 1. 9. PCR reaction 
 
A standard PCR was performed as follows: 
 
For 1 reaction 
 
PCR condition (for genotyping) 
Template 1µ l Initial denaturing 94℃ 10min 
10x PCR buffer 2µ l Denaturing 94℃ 30sec 
10mM dNTP mix 1.6µ l Annealing++ x℃ 30sec 
10µM sense primer 0.5µ l Extension 72℃ 45sec 
10µM anti-sense primer 0.5µ l Final extension 72℃ 10min 
Taq polymerase 0.1µ l Pause 8℃ ∞ 
dH2O 13.8µ l 
  Total 20µ l 
 
++The annealing temperature was changed depending on the used primers. 
The cycle of denaturing, annealing and extension was repeated 35 times. 
 
 
For cloning purpose, a thermostable DNA polymerase with proof-reading capabilities 
was used (pfu polymerase, Promega). 
 
2. 2. 1. 10. Isolation of total RNA 
 
Total RNA was isolated from tissues and cells using the peqGold RNAPure reagent 
(PEQLab, cat# 30-1030). 1ml of peqGold RNAPure reagent was added to 5-10× 106 
cells grown on a 3.5cm petri dish. Cells were lysated and incubated at room 
temperature for 5min for dissociation of nucleoprotein complexes. 0.2ml of 
chloroform was added, the mixture was vigorously mixed for 15sec, and incubated 
on ice for 5min. The tube was centrifuged at 12000× g for 15min at 4℃. 
Subsequently, the upper aqueous phase was transferred to a new Eppendorf tube 
and an equal volume of isopropanol was added. The tube was stored at 4℃ for 
15min to precipitate the RNA and centrifuged at 12000× g for 15min at 4℃. The 
RNA pellet was washed with 1ml of 75% ethanol, centrifuged again at 12000× g for 
10min at 4℃, air-dried for 5min, and finally resuspended in DEPC-treated H2O by 
incubation at 55-60℃ for 10-15min. The RNA concentration was determined using a 
UV-spectrometer.  
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2. 2. 1. 11. Reverse transcription-polymerase chain reaction (RT-PCR) 
 
RT-PCR was performed to determine the mRNA expression level of a specific gene. 
For cDNA synthesis, total RNA (2µg) was isolated from a tissue of interest and used 
under these conditions: 
 
Reverse Transcription (RT): 
For 1 reaction 
Total RNA 2µg 
Oligo(dT)15 primer 10pmol 
DEPC-D.W. 11µ l 
 
Incubation at 70℃ for 5min and then cool down on ice for 5min 
 
For 1 reaction 
5x AMV-buffer 5ul 
10mM dNTPs 2.5µ l 
40U RNAsin 1µ l 
100mM DTT 1µ l 
15U AMV-RT 0.6µ l 
DEPC-D.W. 25µ l 
 
Incubation at 42℃ for 60min 
 
After reverse transcription, the cDNA template was amplified by PCR using gene specific primers.  
 
2. 2. 1. 12. Annealing of oligonucleotides to complementary 
sequences 
 
To anneal oligos nucleotides to complementary DNA sequences, an annealing 
reaction was performed: 
  
Annealing oligos 
10µM Sense primer 10µ l 
10µM Antisense primer 10µ l 
10x NEB#3 Buffer 5µ l 
dH2O 25µ l 
Total 50µ l 
 
The reaction was heated to 95℃ for 2min and gradually cooled down to 30℃ over a period of 45min-1hr.  
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2. 2. 2. Biochemistry methods 
 
2. 2. 2. 1. Yeast two-hybrid methods 
 
The yeast two-hybrid system was first described by Fields and song (1989) for the 
yeast transcription factor GAL4. The system utilizes the fact that in most eukaryotic 
transcription factors, DNA binding and transcriptional activation domains can be 
physically separated. Therefore, the GAL4-DNA binding domain can be fused to any 
protein of which protein interaction shall be tested. This construct is called the bait. 
The GAL4 activation domain then is fused to a potential interacting candidate to 
form the so-called prey construct. It also is possible to use an entire cDNA library 
containing all protein encoding sequences of a particular tissue maybe used as prey 
(Fields and Song, 1989; Chien et al., 1991). Recapitulation of the functional GAL4 
transcription factor depends on interaction of bait and prey proteins. Expression of 
reporter genes harboring GAL4 upstream activating sequences (UASs) can then be 
stimulated. 
 
In order to identify novel Lis1 interacting proteins from the mouse testis, the GAL4-
DBD-Lis1 plasmid together with a testis cDNA library (BD Biosciences, ML4015AH) 
was transformed into the AH109 yeast strain using the small scale transformation 
method. A positive selection screening strategy was used which was based on the 
Gal4-dependent expression of the HIS3 and ADE2 auxotrophic makers to avoid 
false-positives (James et al., 1996). When a bait and prey interaction occurs, the 
HIS3 and ADE2 reporter genes are expressed since they both are brought under 
the control of a GAL4 responsive element (i.e. GAL1 promoter) in the AH109 yeast 
strain. Consequently, yeast cells will grow in a selection medium lacking next to 
histidine also adenine when an adequate protein-protein interaction leads to the 
activation of the two independent reporter systems.   
 
2. 2. 2. 1. 1. Titering a mouse testis cDNA library 
 
A mouse testis matchmaker cDNA library in E. coli cells (BD Biosciences, 
ML4015AH) was thawed on ice and mixed by vortexing. 2ml of the cDNA library was 
diluted in 30ml of LB medium without antibiotics and gently mixed by pipetting. 
150µ l of the diluted library was plated on LB plates (total around 200 plates) 
containing an appropriate antibiotic (ampicillin) and incubated overnight (18-20hrs) 
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at 37℃. The plates were then transferred to a 30℃ incubator and incubated 
additional 6hrs. 5 ml of LB medium containing ampicillin was added to each plate to 
collect all E. coli colonies and incubated again at 30℃ for 2hrs with vigorous 
shaking (200rpm). This culture was stored at 4℃ overnight and plasmid DNA was 
prepared by maxi preparation as described above (section 2.2.1.5.2.). 
 
 
2. 2. 2. 1. 2. Yeast small scale transformation (for screening)  
 
To prepare yeast competent cells, several 2-3mm large colonies were inoculated in 
1ml of YPDA medium by vortexing to disperse any clumps. The cells then were 
transferred to a flask containing 50ml of YPDA medium and incubated at 30℃ for 
16-18hrs with shaking (250rpm) until they reached the stationary phase 
(OD600>1.5). The overnight culture was transferred into 300ml of YPDA medium 
and incubated at 30℃ with shaking (230-270rpm) until an OD600 value of 0.5± 0.1. 
The culture was transferred into 50ml tubes and centrifuged at 3600rpm for 5min 
at room temperature. The cell pellets were resuspended in 50ml of sterile H2O by 
vigorous vortexing. Cells were centrifuged again at 3600rpm for 5min at room 
temperature and the pellet was resuspended in 1.5ml of sterile 1× TE/LiAc. 
Meanwhile 10ml of PEG/LiAc solution was prepared. 0.1ug of DNA of the binding 
domain/bait construct, 0.1µg of the activation domain/prey (library or interesting 
candidate constructs), and 0.1mg of Herring testes carrier DNA were mixed 
together with 0.1ml of yeast competent cells by vortexing. 0.6ml of sterile PEG/LiAc 
solution was added, mixed well by vortexing, and incubated at 30℃ for 30min with 
shaking (200rpm). 70µl of DMSO was added to the mixture by gentle inversion.  
Heat shock was performed for 15min at 42℃. Cells were chilled on ice and 
centrifuged for 5sec. The cell pellet was resuspended in 500µl of YPDA medium and 
plated on SD auxotrophic selection plates lacking the adenine (Ade), histidine (His), 
tryptophan (Tryp), and leucine (Leu) where adenine and histidine served for the 
selection of bait/prey interactions. The amino acids tryptophan and leucine were 
omitted to propagate the BD-bait and the AD-prey plasmids since these plasmids 
express the selection markers “Trp1” and “Leu2”, respectively. The plates were 
incubated at 30℃ until colonies appear. 
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YPDA medium: 
YPDA medium is a mixture of peptone, yeast extract, and dextrose for growth of most strains of 
Saccharomyces cerevisiae (Clontech).  
 
20g Difco peptone 
10g Yeast extract 
20g Agar (for plates only) 
2% Glucose 
Adjust the volume to 1l with dH2O / Autoclave 
 
SD medium: 
6.7g Yeast nitrogen base without amino acids (Difco #0919-15-3) 
20g Agar (for plates only) 
2% glucose 
100ml 10x Dropout Solution  
Adjust the volume to 1l with dH2O and then autoclave 
 
10x Dropout Solution (-Ade/ -His/ -Tryp/ -Leu) (Media recipes, Clontech): 
Nutrient 10× Conc. Sigma Cat. # 
L-Arginine HCl 200mg/L A-5131 
L-Isoleucine 300mg/L I-7383 
L-Lysine HCL 300mg/L L-1262 
L-Methionine 200mg/L M-9625 
L-Phenylalanine 500mg/L P-5030 
L-Threonine 2000mg/L T-8625 
L-Tyrosine 300mg/L T-3754 
L-Uracil 200mg/L U-0750 
L-Valine 1500mg/L V-0500 
 
To prepare 10x Dropout Solution (-Ade/ -His/ -Tryp/ -Leu), combine the nutrients as indicated above, but 
not include adenine, histidine, tryptophan, and leucine. 
 
Herring testes carrier DNA (10mg/ml), K1606-A, Clontech 
 
PEG/LiAc solution (polyethylene glycol/lithium acetate): 
 Final Conc. To prepare 10ml of solution 
PEG 4000 40% 8ml of 50% PEG 
TE buffer 1x 1ml of 10x TE (pH 7.5) 
LiAc 1x 1ml of 10x LiAc (pH 7.5) 
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2. 2. 2. 1. 3. Protein extraction from yeast cultures 
 
To confirm bait protein expression in yeast, the GAL4-DBD-Lis1 plasmid was 
transformed into the AH109 yeast strain and grown in selection medium (lacking 
tryptophan). Protein was extracted using the Urea/SDS method as described below. 
Cells (5ml) were vortexed for 30sec-1min and used to inoculate 50ml YPD medium. 
The culture was incubated at 30℃ with shaking (250rpm) until the OD600 value of 
0.4–0.6. The culture was cooled down on ice, placed into a prechilled centrifuge 
tube, and centrifuged at 1.000× g for 5min at 4℃. The cell pellet was washed with 
50ml ice-cold H2O twice, resuspended in prewarmed cracking buffer, and 
transferred to a 1.5ml screw-cap centrifuge tube containing 80µl of glass beads per 
7.5 OD600 units of cells. The sample was incubated at 70℃ for 10min, mixed 
vigorously by vortexing for 1min, and centrifuged at 14.000rpm for 5min at 4℃. 
The supernatant was transferred to a new tube and placed on ice. The remaining 
pellet was treated again by boiling at 100℃ for 5min and mixed vigorously by 
vortexing for 1min. The sample was centrifuged at 14.000rpm for 5min at 4℃. Both 
supernatants were combined. The protein concentration was determined by 
Bradford assay. 10µg from the lysate were loaded on a 10% SDS-PAGE gel, 
transferred onto a nitrocellulose membrane, and probed with an anti-Lis1 antibody 
(Sigma). 
 
 
Protease inhibitor solution: 
Name  To prepare 688ul 
Type of protease 
inhibited: 
Pepstatin A 
(Sigma #B4268) 
0.1mg/ml 
66ul of a 1mg/ml stock 
solution in DMSO 
Carboxyl protease 
Leupeptin 
(Sigma #L2884) 
0.03mM 
2ul of a 10.5mM stock 
solution 
Some thiol and serine 
proteases 
Benzamidine 
(Sigma #B6506) 
145mM 
500ul of a 200mM stock 
solution 
Trypsin, plasmin and 
thrombin 
Aprotinin 
(Sigma #B6506) 
0.37mg/ml 
120ul of a 2.1mg/ml stock 
solution 
Some serine proteases 
PMSF 
(Sigma #P7626) 
  Serine proteases 
EDTA   Metalloproteases 
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PMSF (phenylmethyl-sulfonyl fluoride) 100×  stock solution: 
0.1742g PMSF 
Dissolve in 10ml isopropanol 
Warp with foil and store at room temperature 
 
Glass Beads (Sigma #G-8772) 
 
Cracking buffer stock solution: 
  To prepare 100ml 
Urea 8M 48g 
SDS 5% w/v 5g 
Tris-HCl (pH6.8) 40mM 4ml of a 1M stock solution 
EDTA 0.1mM 20µ l of a 0.5M stock solution 
Bromophenol blue 0.4mg/ml 40mg 
dH2O  To a final volume of 100ml 
 
Cracking buffer (complete): 
 To prepare 1.13ml of Cracking buffer 
Cracking buffer stock sol. 1ml 
-mercaptoethanol 10µ l 
Protease inhibitor sol. 70µ l 
PMSF 50µ l of 100x stock sol. 
 
 
2. 2. 2. 1. 4. Isolation of plasmid DNA from yeast 
 
Plasmid DNA was isolated from yeast cells by inoculation of a single yeast colony in 
5ml prewarmed high stringency selection medium (-Ade/ -His/ -Tryp/ -Leu +2% 
glucose). The culture was incubated at 30℃ for 16-18hrs with shaking (200rpm) 
and centrifuged for 1min at 3600rpm at room temperature. The cell pellet was 
dissolved in 75µl of yeast-suspension buffer and incubated at 37℃ for 30min. 
Subsequently, 425µl of yeast lysis buffer was added and transferred into an 
Eppendorf tube containing 400µl of glass beads. 400µl of chloropan was added and 
mixed for 5min by vortexing. The tube was centrifuged for 10min at 13000rpm. The 
supernatant containing DNA was transferred to a fresh tube, ammonium-acetate 
was added (final concentration of 0.4M), and DNA was precipitated with an equal 
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volume of isopropanol. The tube was centrifuged for 10min at 13000rpm and the 
DNA pellet was washed with 70% EtOH, air-dried, and dissolved in 20µl of dH2O. 
The shuttle vector plasmid DNA was then transformed into competent XL1-Blue 
bacterial cells and incubated on plates containing ampicillin.  
 
Yeast suspension buffer:  
Component 1l 
1M tris-HCl (pH 8.0) 10ml 
0.5M EDTA 2ml 
 
Adjust the volume to 1l with dH2O 
Sterilize by filtration, store at 4℃ and add Lyticase (4.5units/µ l) directly before usage 
 
Yeast lysis buffer: 
Component 500ml 
Triton X-100 10ml 
SDS 5g 
NaCl 2.9g 
1M Tris-HCl (pH 8.0) 5ml 
0.5M EDTA (pH 8.0) 1ml 
 
Adjust the volume to 500ml with dH2O 
Sterilize by filtration 
 
 
2. 2. 2. 1. 5. Co-transformation assay 
 
Results from the small scale transformation assay were verified by 
cotransformations into yeast cells. Several controls were included in these assays. 
Each of the identified Lis1 binding partners linked to the activation domain of GAL4 
were cotransformed into yeast strain AH109 together with Lis1 fused to the GAL4 
DNA binding domain. Moreover, to assay the specificity of the GAL4-DBD-Lis1 bait 
construct, a fusion of the SV40 large T-antigen (aa 84-708) with the GAL4 
activation domain served as control. In addition, a NudeL-GAL4-AD construct served 
as a positive control for the assay. Additionally, human Lamin C fused to the LexA 
DNA binding domain was used as a non-specific bait construct in combination with 
the identified Lis1 binding partners fused to an appropriate activation domain. 
These constructs were cotransformed into L40 yeast strain containing LexA-
responsible auxotrophic markers. All transformed cells were plated on nonselective 
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and selective plates. Under selection conditions (-Ade/ -His/ -Tryp/ -Leu), cells only 
can grow when the Ade2 and His3 reporters are activated by protein-protein 
interactions. 
 
2. 2. 2. 2. GST pull-down methods 
 
For GST pull-down assays, one binding protein physically linked to glutathione-S-
transferase (GST fusion protein) is coupled to glutathione sepharose beads which 
subsequently are incubated with an in vitro translated [S35] binding partner protein. 
After extensive washings, to remove non-specific protein associations, specifically 
bound protein is separated by SDS-PAGE and detected by autoradiography. 
 
2. 2. 2. 2. 1. Preparation of 50% slurry 
 
Glutathione Sepharose 4B suspension (Amersham) was gently mixed by inversion 
and transferred to a new container in which it was centrifuged at 500xg for 5min. 
The supernatant was carefully removed and the pellet was washed three times by 
adding 10 bed volumes of cold 1×  PBS. Finally, an appropriate volume of 1×  PBS 
was added to obtain a 50% slurry. 
 
2. 2. 2. 2. 2. Purification of GST fusion protein 
 
pGEX recombinant plasmids were transformed into the E. coli strain BL21. A single 
fresh colony was inoculated in 5ml of 2×  YTA medium and incubated at 37℃ for 12-
15hrs. The culture was diluted 1:100 into prewarmed 2×  YTA medium containing 
2% glucose and cultivated at 30℃ with shaking (230-270rpm) until the culture 
reached an OD600 of 0.6-0.8. 100mM Isopropyl--D-thiogalactopyranosid (IPTG) 
was added to induce fusion protein production and incubated for an additional 3hrs. 
The culture was placed on ice for 10min and centrifuged at 8000rpm for 10min at 
4℃. The pellet was resuspended in 20ml of an ice-cold 1×  PBS. Cells were 
disrupted by 5 cycles of each consisting of a 30 seconds sonication period (output 
of 2.0 watts) followed by 1 minute cooling period on ice. To help solubilization of 
the fusion protein, Triton X-100 was added to the disrupted cells at a final 
concentration of 1%. The suspension was mixed gently on a rotating wheel for 
30min at 4℃. After centrifugation at 10,000rpm for 10min at 4℃, the supernatant 
was transferred to a fresh container, and incubated with 200µl of a 50% slurry of 
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Glutathione Sepharose 4B beads on a rotating wheel for 30min at room 
temperature. After centrifugation at 500xg for 5min, the beads were washed 
carefully by inverting with 10 bed volumes of 1x PBS and centrifuged again at 
500× g for 5min. The washing step was repeated twice more. The purified fusion 
protein was analyzed on a SDS-PAGE gel. Alternatively 200µl of elution buffer was 
added to the beads to elute bound protein and incubated using a rotating wheel for 
10min at room temperature. After spinning at 500× g for 5min 4℃, eluted protein 
was transferred to a fresh tube. This elution step was repeated 3 times. Each step 
of eluted proteins was measured by Bradford assay. 
 
2. 2. 2. 2. 3. in vitro translation  
 
In vitro translation was performed following the instruction of the TNT Reticulocyte 
Lysate System from Promega, a coupled transcription/ translation system requiring 
SP6, T3 or T7 RNA polymerase promoters to synthesize specific proteins. In vitro 
translated proteins can be radiolabeled using [35S] methionine and used to analyze 
protein-protein interactions with GST fusion proteins.  
 
Table TnT Lysate Reactions: 
Component Standard Reaction using [35S]Methionine 
TnT Rabbit Reticulocyte Lysate 25µ l 
TnT Reaction Buffer 2µ l 
TnT RNA polymerase (T7) 1µ l 
Amino Acid Mixture, Minus Methionine 1mM 1µ l 
[35S]Methionine 2µ l 
RNasin Ribonuclease Inhibitor 1µ l 
DNA template (0.5µg/ul) 2µ l 
Nuclease-Free Water to a final volume of 50µ l 
 
 
The reaction was incubated at 30℃ for 90 min. 5µ l (10%) of the entire reaction 
(50µl) was loaded on a SDS-PAGE gel to monitor the translation process. It was 
mixed with SDS sample buffer and denatured at 95℃ for 5min. Electrophoresis was 
performed at 100V for 2hrs. The polyacrylamide gel was placed first in destaining 
solution for 1hr and then in distilled water for an additional 30min. Finally, to 
enhance the detection sensitivity of radiation signals, the gel was incubated in 1M 
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sodium salicylate solution for 1hr. The gel was placed on a Whatman filter paper, 
covered with saran wrap, and dried at 60℃ for 1-2hrs utilizing a vacuum gel dryer. 
The dried gel then was exposed on an X-ray film at room temperature. 
 
2. 2. 2. 2. 4. GST pull- down assay 
 
20µg of purified beads to which GST-Lis1 fusion protein had been bound were 
incubated with a sample of 45µl of [35S] radiolabeled in vitro translated proteins on 
a rotating wheel over night at 4℃. To avoid unspecific binding, the beads were 3 
times washed by carefully inverting with 10 bed volumes of 1×  PBS and subsequent 
centrifugation at 500× g for 5min. Bound proteins were denatured with SDS-sample 
buffer and heating at 95℃ for 5min and separated on a SDS-PAGE. Dried gels were 
exposed on X-ray films.  
 
Reagents for purification of pGEX recombinants: 
Product Catalog # Company 
Glutathione Sepharose 4B 17-0756-01 Amersham 
TnT Coupled Reticulocyte Lysate system L4610 Promega 
Rnasin Ribonuclease inhibitor N2111 Promega 
Redivue L-[35S] Methionine AG1094 Amersham 
isopropyl--D-thiogalactoside (IPTG) 27-3054-03 Amersham 
Anti-GST antibody 27-4577-01 Amersham 
 
2×  YTA medium: 
2×  YT + 100µg/ml ampicillin 
16g tryptone 
10g yeast extract 
5g NaCl in 900ml of distilled H2O. 
Adjust the pH to 7.0 with NaOH. 
Adjust the volume to 1l with dH2O 
Autoclave 
Add ampicillin stock solution to a final concentration of 100µg/ml 
 
100mM IPTG: 
Dissolve 500mg of isopropyl--D-thiogalactoside (IPTG) in 20ml of distilled H2O 
Filter-sterilize and store at -20℃ 
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Elution buffer: 
50mM Tris-HCl 
10mM reduced glutathione  
pH 8.0 
store at -20℃ 
Avoid more than five freeze/thaw cycles 
  
Destaining solution: 
450ml Methanol 
100ml acetic acid 
450ml dH2O 
 
Sodium Salicylate: 
32g sodium salicylate 
Add 200ml dH2O 
 
TBST: 
20mM Tris-HCl (pH 8.8) 
140mM NaCl  
0.1% Tween 20 
 
 
2. 2. 2. 3. Coimmunoprecipitation assay 
 
Coimmunoprecipitation allows the detection of protein-protein interactions in a 
tissue or a cell line and utilizes an antibody specifically binding to one of the 
interaction partners. Protein-G sepharose functions to “precipitate” this immune 
complex including proteins associated with the antibody bound antigen. Interaction 
partners can then be visualized by Western blot using appropriate antibodies. For 
this assay, Lis1 and candidate interacting proteins were subcloned into a 
mammalian expression vector pcDNA3.1 containing Flag or HA epitope tags.  
 
4× 105 of COS-7, HeLa or HEK293T cells were seeded in 6 well dishes and on the 
following day, cells were transiently transfected with expression plasmid of Flag 
tagged Lis1 and HA tagged candidate interacting proteins using Lipofectamine 2000. 
HA antibody coupled beads were prepared by washing of Protein G-sepharose 
   
Materials and Methods │ 35 
beads (Ezview red protein G affinity gel, Sigma) with lysis buffer and incubation 
with HA antibody for 2hrs at 4℃. These antibody coupled beads were washed 
3times with lysis buffer. Cells were lysed by adding 100µl of lysis buffers (RIPA or 
1% Triton X-100 lysis buffer containing a protease inhibitor cocktail (Roche) 
including 1mM EDTA. Extracts were centrifuged at 13,000rpm for 15min 4℃ for two 
times to remove cellular debris and incubated with 20µ l of HA antibody coupled 
protein G-Sepharose beads using rotary agitation overnight at 4℃. 
Immunoprecipitates were washed with lysis buffer. Proteins were separated on a 
SDS-PAGE gel. Flag-tagged binding partners could be detected by an anti-Flag 
antibody. 
 
Reagents for coimmunoprecipitation: 
Product Catalog # Company 
EZview Red Protein G Affinity Gel E3403 Sigma 
HA11 MMS-101R Covance 
Anti-Flag BioM2 F9291 Sigma 
Streptavidin-Peroxidase S5512 Sigma 
Lipofectamine 2000 11668-019 Invitrogen 
protease inhibitor cocktail tablets, 
EDTA-free 
04 693 159 001 Roche 
 
 
 
RIPA buffer (for NudeL, ACT and BRAP): 
10% NaDoC (Deoxycholic acid Sodium salt monohydrate) 
100mM Tris-HCl (pH 7.5) 
20% SDS 
5M NaCl 
1% NP-40 
 
1% Triton X-100 lysis buffer (for Ranbp9):  
1% Triton X-100 
20mM Tris-HCl (pH 7.5)  
50mM NaCl 
50mM NaF 
15mM Na4P2O7·10H2O 
2mM Na3VO4 
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The protease inhibitor cocktail, EDTA free (Roche) is able to inhibit efficiently serine 
and cysteine proteases. Metalloproteases were blocked by the addition of EDTA 
(1mM). 
 
 
2. 2. 2. 4. Determination of protein concentration using Bradford 
assay 
 
The protein concentration was determined by Bradford assay (Bradford reagent 
#5000205, Biorad). A standard curve was always prepared using BSA (Bovine 
Serum Albumin standard set #5000207, Biorad) at different concentrations 
(ranging from 0.125 to 2.0mg/ml). 10ul samples were incubated with 990µl of 
Bradford reagent for 10min. OD values were measured using a spectrophotometer 
at 595nm.  
 
 
2. 2. 2. 5. SDS-PAGE gel electrophoresis 
 
SDS-PAGE gels were used to separate proteins according to their molecular weight 
(Laemmli, 1970). For this purpose, protein extracts were incubated in SDS-sample 
buffer (1.75mM Tris-HCl pH 6.8, 10.28% SDS, 36% glycerol, 0.012% bromphenol 
blue, 5% 2-mercaptoethanol) at 95℃ for 5min, then cooled on ice, and 
centrifuged at 4℃ for 5min at full speed. Samples were loaded on the SDS-PAGE 
gel always together with a standard molecular weight maker. Different 
concentrations of acrylamide gels were used depending on the molecular weight of 
the proteins to be separated.  
 
 
Compositions of separating SDS-PAGE gels: 
Component 8% 10% 12% 15% 
H2O 2.7ml 2.45ml 2.2ml 1.825ml 
4x separating buffer 1.25ml 1.25ml 1.25ml 1.25ml 
40% acrylamide 1ml 1.25ml 1.5ml 1.875ml 
10% APS 50µ l 50µ l 50µ l 50µ l 
TEMED 2µ l 2µ l 2µ l 2µ l 
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Compositions of stacking SDS-PAGE gels: 
Component 15% 
H2O 1.22ml 
4x stacking buffer 500µ l 
40% acrylamide 250µ l 
10% APS 20µ l 
TEMED 2µ l 
 
Gels were run at a constant voltage of 100V. Proteins were subsequently visualized 
by staining with Coomassie brilliant blue solution (0.025% Coomassie brilliant blue 
R250, 40% methanol, 7% acetic acid in 2 liters).  
 
2. 2. 2. 6. Western blotting 
 
Proteins were transferred to nitrocellulose membranes using a semidry blotting 
apparatus (Biometra) for 2hrs at constant current of 57mA. After blotting, 
membranes were usually stained with Ponceau S solution (Sigma #7170) to 
confirm transfer efficiency. The membrane was then blocked with 5% skimmed milk 
powder in TBST at room temperature for 1hr and subsequently incubated with a 
primary antibody at 4℃ overnight (16-18hrs). The membrane was washed 3times 
for 10min with TBST before an appropriate the secondary antibody conjugated to 
horseradish peroxidase was added for 1h at room temperature. The membrane was 
rinsed 3 times for 10min in TBST. Enhanced Chemiluminescence (ECL)(Amersham 
and Thermo) following the manufacture instructions was performed and exposed to 
an X-ray film (Fuji). The antibody dilutions are given in section 2.1.6.  
 
4×  Separating buffer: 
Component 100ml 
2M tris-HCl (pH 8.8) 75ml 
10% SDS 4ml 
H2O 21ml 
 
4×  Stacking buffer: 
Component 100ml 
1M tris-HCl (pH 6.8) 50ml 
10% SDS 4ml 
H2O 46ml 
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10×  Running buffer (pH 8.3): 
Component 1l 
Tris-base 30.3g 
Glycine 144g 
SDS 10g 
Adjust the volume to 1l with dH2O 
 
 
 
10×  Blotting buffer (pH 8.3): 
Component 1l 
Tris-base 30.3g 
Glycine 144g 
Adjust the volume to 1l with dH2O 
 
 
 
1×  Blotting buffer (pH 8.3): 
Component 1l 
Methanol 200ml 
10x blotting buffer 100ml 
H2O 700ml 
 
 
 
6×  SDS-sample buffer: 
Component 10ml 
1.75M tris-HCl (pH 6.8) 2ml 
SDS 1.028g 
100% glycerol 3.6ml 
2mercaptoethanol 500µ l 
Bromophenol blue 0.0012g 
Adjust the volume to 10ml with dH2O 
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2. 2. 2. 7. Bimolecular fluorescence complementation assay 
 
To examine the protein-protein interactions in living mammalian cells, bimolecular 
fluorescence complementation (BiFC) assays were performed. In principle, this 
technique is based on a fluorescent reporter protein which is divided into two 
fragments, an amino- and a carboxy-terminal part. Each fragmented reporter 
protein is linked to candidate binding protein partners, so that reconstitution of the 
fluorescent reporter protein depends on the interaction between the fusion proteins. 
The reconstituted fluorophore is able to emit defined fluorescent signals which can 
be detected by confocal microscopy or quantified by FACS (fluorescence activated 
cell sorting).  
 
2. 2. 2. 7. 1. Procedure to detect the Venus fluorophore signals 
using a confocal laser-scanning microscopy 
 
1× 105 HeLa cells were seeded on 24 well plates containing sterile cover slides. After 
24hrs, appropriate Venus fusion constructs of Lis1 and interaction partners were 
cotransfected into HeLa cells using the Lipofectamine 2000 transfection reagent 
(Invitrogen). 24hrs after transfection cells were washed one time with 1×  PBS and 
fixed then by 95% ethanol in the dark for 10min at room temperature. Cells were 
washed with 1×  PBS and subsequently nuclei were stained by 4'-6-Diamidino-2-
phenylindole (DAPI) (1µg/ml) for 10min at room temperature. The cells were 
washed with 1x PBS and mounted using aqueous mounting medium to prevent 
fading of the fluorescence. The Venus fluorophore signals were analyzed using a 
Carl Zeiss LSM510 confocal microscopy and with 488nm laser light for excitation. 
 
2. 2. 2. 7. 2. Procedure to quantify the Venus fluorophore signals 
using a FACS  
 
1× 105 HeLa cells were transfected as described above. 24hrs later, cells were 
washed with 1×  PBS and detached from the wells by trypsin-EDTA in the dark. 
DMEM growth medium (10% FCS, 1% penicillin/streptomycin, and 1% L-glutamine) 
was added and cells were centrifuged at 1000rpm for 5min. The cell pellet was 
resuspended in FACS buffer (2% FCS in 1×  PBS containing 0.5mM EDTA pH. 8.0). 
10,000 cells were analyzed in the FL1 channel of a FACS machine (Becaman) able 
to excite and detect Venus fluorophore signal at 530nm (+/-10nm). 
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2. 2. 2. Cell biology methods 
 
2. 2. 2. 1. Mammalian cell cultivation 
 
Cells were maintained in Dulbecco’s modified Eagle Medium (DMEM, PAA 
Laboratories) supplemented with 10% fetal calf serum (FCS), 1% 
penicillin/streptomycin, and 1% L-glutamine in an incubator at 37℃, 10% CO2, and 
99% humidity.  
 
2. 2. 2. 2. Generation of immortalized mouse embryonic fibroblast 
cells  
 
Primary mouse fibroblast cells (MEFs) were prepared using wild type as well as 
Lis1wt/flox and Lis1flox/flox embryos at embryonic day E13.5. The embryo head were 
collected for genotyping. After removal of the internal organs from the embryo, 
body tissues were used to generate immortalized mouse embryonic fibroblast cells. 
The tissues were mechanically dissociated by pipetting and subsequently 
dissociated using trypsin/EDTA. 2ml DMEM growth medium supplemented with 10% 
FCS, 2% chicken extract, 1% penicillin/streptomycin, and 1% L-glutamine were 
added to the suspension and mechanically dissociated again using a Pasteur pipette. 
Single cell suspensions were maintained in DMEM growth medium. To establish a 
stable cell line, cells were transferred every 2-3 days to a new culture dish until 
cells stopped dividing and underwent crisis. After then, cells were able to grow 
again and maintained in DMEM medium supplemented with 10% FCS, 1% 
penicillin/streptomycin, and 1% L-glutamine.  
 
2. 2. 2. 3. Transfection 
 
1× 105 cells were seeded in 24 wells in DMEM medium supplemented with 10% FCS 
and 1% L-glutamine without antibiotics one day before transfection. At the 
following day, each of 0.8µg plasmid DNA and 2µ l Lipofectamine 2000 (Invitrogen, 
cat# 11668-019) was diluted in 50µl of DMEM medium without FCS and antibiotics. 
Subsequently, both solutions were gently combined and incubated for 20min at 
room temperature. This mixture was directly added to the culture plate and gently 
mixed again. Cells were maintained at 37℃ and 10% CO2 incubator for various time 
points. 
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2. 2. 2. 4. Adenovirus-CRE recombinase infection 
 
0.2-0.5× 105 cells were seeded in 24 well plates with DMEM growth medium 
supplemented with 10% FCS, 1% penicillin/streptomycin, and 1% L-glutamine. 
24hrs later, 1.5× 107 PFU of recombinant adenovirus able to express CRE 
recombinase tagged with the GFP fluorophor (AD-CRE, Vector Biolabs, cat# 1700) 
was diluted in DMEM growth medium. Cells were incubated with the virus diluted 
growth medium in a 37℃, 5% CO2 incubator for various time points. 
 
2. 2. 2. 5. Amplification of adenovirus 
 
The used recombinant adenovirus (Vector Biolabs) can replicate in the HEK293T 
cells supplying the missing viral genes such as E1 and E3 (Graham et al., 1977). 2-
3× 105 HEK293T cells were seeded in 6 well plates with DMEM growth medium 
supplemented with 10% FCS, 1% penicillin/streptomycin, and 1% L-glutamine. 
24hrs later, cells were incubated with 1.5× 107 PFU virus in growth medium. The 
virally infected cells were harvested after 40-48hrs and centrifuged at 4000 rpm for 
15min at 4℃. The supernatant was carefully removed and the cell pellet was 
resuspended in 2×  viral storage buffer. The cells were immediately frozen on dry ice 
and stored at -80℃. Cells were thawed rapidly and frozen using dry ice. This step 
was repeated 3 times and then the tubes were centrifuged at 3200rpm for 10min at 
4℃. The supernatant containing recombinant adenovirus was removed and 
transferred to a fresh tube. A small aliquot used to determine the viral titer.  
 
2×  viral storage buffer: 
10mM Tris (pH8.0) 
100mM NaCl 
0.1% BSA 
50% glycerol 
After filtration, storage at 4℃ 
 
2. 2. 2. 6. Titration of recombinant adenovirus 
 
Titration of recombinant adenovirus was monitored by GFP expression (He et al., 
1998). 0.8× 105 MEF cells were seeded on 24 wells with 13 mm round coverslips. At 
the following day, cells were infected with serially diluted samples of the virus 
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containing cell lysate (1, 2, 5, 7, and 10µ l) (prepared as described in 2.2.2.6.) for 
72hrs. After then, cells were fixed using 4% PFA for 10min at room temperature, 
and counterstained with DAPI (1µg/ml). The coverslips were mounted using an 
aqueous non-fading mounting medium to preserve the GFP fluorescence. The GFP 
positive cells infected by recombinant adenovirus were counted using the 
fluorescence microscope (Zeiss).  
 
2. 2. 2. 7. Immunocytochemistry 
 
1× 105 cells were plated on 24 wells with 13mm round coverslips. Cells were 
washed with PBS and fixed with an appropriate fixation solution at room 
temperature for various time points. Cells were washed three times with PBS to 
remove remaining fixation solution. To reduce nonspecific antibody binding, cells 
were first blocked in blocking buffer (2-3% FCS in PBS) for 1hr at room 
temperature and then subsequently incubated with the diluted primary antibody for 
2hrs at room temperature or overnight at 4℃. Cells were washed with blocking 
buffer and the diluted secondary antibody was added for 1hr at room temperature. 
Cells again were washed three times with blocking buffer. 4', 6-Diamidino-2-
phenylindole, dihydrochloride (DAPI) at 1µg/ml was added for 10min to visualize 
nuclei. Cells were washed two times with PBS. Coverslips were mounted using an 
aqueous mounting medium able to prevent fading of the fluorescence. 
 
Fixation solutions and blocking buffers in different antibodies staining on cells:  
Staining Fixation solution Blocking buffer 1° AB 2° AB 
Tagged in Hela cells 
(HA, Flag and eGFP) 
95% Ethanol for 10min 2% FCS in PBS 1:250 1:250 
Anti-goat Ranbp9  
in Hela cells 
4% PFA for 10min 2% FCS in PBS 1:250 1:250 
Anti-mouse Lis1  
in Hela cells 
95% Ethanol for 10min or 
4% PFA for 10min 
2% FCS in PBS 1:250 1:250 
Anti-mouse 
Lis1 in MEF cells 
Methanol for 5min at -20℃  
4% PFA for 10min 
0.2% Triton X-100 
3% FCS in PBS 
1:250 1:200 
Anti-goat 
Ranbp9 in MEF cells 
Methanol for 5min at -20℃ 
4% PFA for 10min 
0.2% Triton X-100 
3% FCS in PBS 
1:100 1:200 
Anti-mouse  
-tubulin in MEF cells 
95% Ethanol for 10min 
0.2% Triton X-100 
3% FCS in PBS 
1:500 1:500 
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Staining Fixation solution Blocking buffer 1° AB 2° AB 
Tagged in MEF cells 
(HA and eGFP) 
4% PFA for 10min 
0.2% Triton X-100 
3% FCS in PBS 
1:250 1:200 
 
 
Fixation solutions and blocking buffers for microtubule (MT) and MT-TIP binding 
proteins: 
Staining Fixation solution 
Blocking 
buffer 
1° AB 2° AB 
Anti-mouse--tubulin 
Methanol containing 1mM 
EGTA for 10-15min at -20℃ 
 
4% PFA for 15-20min at RT 
 
Permeablization for 10min 
in 0.15% Triton X-100 in 
PBS 
0.05% Tween 20 
1% BSA in PBS 
 
1:50,000 1:200 
Anti-mouse-Glu-tubulin 1µg/µ l 1:200 
Anti-rat-Tyrosinated-tubulin 1µg/µ l 1:200 
Anti-mouse-Acetylated-tubulin 1:200 1:200 
Anti-rabbit-CLIP115 1:250 1:500 
Anti-rabbit-CLIP170 1:250 1:500 
Anti-mouse-EB1 1:500 1:200 
Anti-mouse-p150glued 1:200 1:200 
 
 
2. 2. 2. 8. Staining the Golgi complex in living cells 
 
1× 105 cells were plated on 24 wells with sterile round cover slides. Cells were 
rinsed with Hanks’ buffered salt solution containing 10mM HEPES (pH 7.4) 
(HBSS/HEPES) and incubated with 5µM BODIPY TR C5 ceramide-BSA (Molecular 
Probes, B-34400) in HBSS/HEPES for 30min at 4℃. To remove remaining ceramide-
BSA complexes, cells were washed three times with ice-cold growth medium and 
then incubated in fresh growth medium at 37℃ for an additional 30min. Cells were 
washed once more and fixed with 4% PFA at room temperature for 10min. After 
washing the cells with 1×  PBS, nuclei were counterstained by DAPI (1µg/ml) for 
10min at room temperature. The cells were washed with 1x PBS once more and 
then mounted using aqueous mounting medium containing an anti-fading agent. 
The signals were analyzed using a confocal microscopy and a laser at 589nm 
excitation. 
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2. 2. 3. Histology methods 
 
2. 2. 3. 1. Paraffin section of tissues 
 
Mouse testes were collected in 1×  PBS and fixed in a solution of 4% formaldehyde 
in PBS at 4℃ overnight with gently shaking or rotating. Subsequently, the samples 
were washed with 1×  PBS at 4℃ for 30min and then washed again twice with 1×  
TBS at 4℃ for 30min. The tissue was permeablized with 0.3% Triton X-100 in 1×  
TBS containing 5% BSA for 2hrs at 4℃ and washed with 1×  TBS containing 1% 
BSA at 4℃ for 1hr. The testes were dehydrated through a EtOH series (25%-100% 
EtOH) and cleared in Xylenes. Subsequently, paraffin infiltration was performed with 
Xylene: Paraffin (1:1 dilution) at 60℃ for 1hr and then the testes were incubated in 
melted paraffin at 60℃ overnight. At the following day, the testes were embedded 
in paraffin and stored at room temperature. 
 
Paraffin embedded sections were cut at 10µm and collected on poly-D-lysine coated 
slides which were dried at 40℃ for 30min and then stored at room temperature for 
further analysis.  
 
2. 2. 3. 2. Immunohistochemistry 
 
Paraffin sections were deparaffinized through Xylene and EtOH series steps. After 
deparaffinization, the slides were washed with PBS. Most antigens are not 
recognized by specific antibodies due to the fixation and the paraffin embedding 
procedure. For this reason, an antigen-retrieval procedure was performed. 2.4ml 
antigen unmasking solution (Vector Lab. Inc. #H-3300) was dissolved in 250ml H2O 
and boiled in a microwave oven. When antigen unmasking solution had cooled 
down to 55℃, the slides were added to this solution and boiled for 3-4min in a 
microwave oven. Subsequently the slides were cooled down to 55℃ at room 
temperature and then shortly boiled again in a microwave oven. The slides were 
allowed to cool and then washed in PBS. To prevent non-specific antibody binding, 
the sections were blocked with 2% FCS in PBS containing 0.1% Tween 20 for 2hrs 
at room temperature and then incubated with the primary antibody (antibody 
dilutions are given in section 2.1.6 Antibodies) overnight at 4℃. The slides were 
rinsed in PBS and subsequently incubated with an appropriate secondary antibody 
for 2hrs at room temperature. The slides were washed in PBS and nuclei were 
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stained with DAPI (1µg/ml). The slides were mounted using aqueous non-fading 
mounting medium (Gel/Mount, cat# 17985-10). The protein expression was 
examined using a fluorescence microscope (Zeiss). 
 
2. 2. 4. Image acquisition and analysis 
 
Most of images were taken using either a fluorescence microscope (40×  oil-
immersion objective, Zeiss) controlled by the Metamorph software or a Carl Zeiss 
LSM510 confocal microscopy. 
 
2. 2. 4. 1. Analysis of +TIP comets of CLIP-170 and CLIP-115 
 
The fluorescence images of +TIP comets of CLIP-170 and CLIP-115 at growing 
microtubule plus ends was acquired using a 63×  oil-immersion objective of 
microscope (Zeiss) controlled by the Metamorph software. The comet tail lengths of 
the end-decorating CLIP-170 and CLIP-115 were measured by using the NIH 
ImageJ program. More than 1000 comets from over 10 independent cells were 
examined for statistical analysis. The comet tail length of CLIP-170 and CLIP-115 is 
expressed by the mean ± standard deviation. 
① ②
③
④
 
Figure 4. Analysis of comet tail lengths of the CLIP-170 and CLIP-115 in mouse embryonic 
fibroblast cells 
To analyze 63x images of comet tail lengths of CLIP-170 and CLIP-115, the NIH ImageJ program was 
used in this study. For measurement of distance in pixels, the scale set up of 1µm corresponds to 9.8 
pixels as descried in the reference to ImageJ.  
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2. 2. 4. 2. Imaging of GFP-EB1 labeled the plus-end of growing 
microtubules and analysis 
 
GFP-EB1 (a kind gift of Prof. Wehland) and mCherry-CRE recombinase were 
transiently cotransfected into wild type and Lis1flox/flox MEFs using Lipofectamine 
2000. 24hrs later, single cells coexpressing GFP-EB1 and mCherry-CRE were 
imaged every 4s for 5min using a 100×  oil-immersion objective (Zeiss) controlled 
by the Metamorph software. Growth velocity of microtubules was determined by 
Metamorph software using the point segment tool. For quantitative analysis, wild 
type (105 MT ends in 8 cells) and Lis1flox/flox MEFs (75 MT ends in 5 cells) were 
examined. Each displayed value represents the mean value ±  standard deviation. 
Statistical significance was evaluated by t-test. 
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3. Results 
 
3. 1. The identification of novel interaction partners of Lis1 protein 
 
3. 1. 1. Yeast two-hybrid screening of mouse testis 
 
In order to investigate the cellular functions of Lis1 during spermatogenesis, I 
identified novel interaction partners of Lis1 using the yeast two-hybrid method. The 
screen was performed with a mouse testis cDNA library.  
 
In this study, the bait vector was constructed by inserting the entire open reading 
frame of murine Lis1 cDNA (U95116) downstream of the GAL4 DNA binding domain 
(DBD) as described in detail under Material and Methods (Fig. 5A). DNA sequencing 
of the GAL4-DBD-Lis1 junction confirmed the continuous open reading frame (ORF). 
The recombinant GAL4-DBD-Lis1 fusion protein has a calculated molecular weight 
of 62kDa. Expression of the Lis1 fusion protein in yeast was confirmed on a 
Western blot (Fig. 5B). 
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Figure 5. The Lis1 fusion protein as bait for yeast two-hybrid analysis  
A. Schematic representation of the GAL4-DNA binding domain (DBD)-Lis1 fusion protein. Individual 
structural domains are indicated.  
B. Expression of a Lis1 fusion protein in the yeast strain AH109. Proteins were identified on Western blot 
with  Lis1 mono clonal antibody. Lane 1: endogenous Lis1 protein (45kDa) in a mouse brain extract. 
Lane 2: GAL4-DBD-Lis1 fusion protein (62kDa) in yeast. Lower bands indicate some degradation. 
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The high stringency yeast two-hybrid screen yielded 26 positive clones (Table 1). To 
further characterize these clones by sequence analysis, E. coli was transformed with 
plasmid DNA from individual yeast clones at low DNA concentration. For each yeast 
clone, two individual E. coli colonies were picked, amplified, and isolated plasmid 
DNA was sequenced. All DNA sequences were annotated by alignments in the 
GenBank database (NCBI). The sequencing results confirmed that all obtained 
clones were in frame with the GAL4 activation domain. 
 
Among the 26 yeast clones, 6 coded for NudeL, a protein already known to interact 
with Lis1. This repetitive isolation of NudeL provided good evidence that in principle 
the bait construct was functional in the yeast two hybrid screening. Another 6 yeast 
clones coded for the Ran binding protein 9 (Ranbp9). Four individual clones were 
isolated coding for the LIM-only protein ACT, while 3 additional clones contained 
sequences of BRCA1-associated protein (BRAP). Further single clones were found 
for tubulin alpha 3B, protamine 1, non-metastatic cells 5, ring finger protein 138, 
and histone H3B. Three clones could not be identified due to failing transformation 
or sequencing. 
 
Since Ranbp9, ACT, and BRAP clones were independently isolated several times in 
the screen, their association with Lis1 protein was considered significant. Therefore, 
these clones were subjected to further analysis. 
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Table 1. List of potential Lis1 interacting proteins identified in yeast two-hybrid clones 
  
Yeast colonies E·coli clones Accession Description 
A1 A1-2 
NM_023668 
Mus musculus 
 nuclear distribution gene E-like homolog 1 
NudeL protein 
A2 
A2-1 
A2-2 
7 7-1 
11 11-1 
14 
14-1 
14-2 
18 18 
A4 
A4-1 
A4-2 
NM_028227 
Mus musculus  
BRCA1 associated protein (BRAP) 
17 17 
22 
22-1 
22-2 
3 3-1 
NM_019930 
Mus musculus 
 RAN binding protein 9 (Ranbp9) 
6 
6-1 
6-2 
9 
9-1 
9-2 
16 
16-1 
16-2 
19 19-2 
20 
20-1 
20-2 
5 
5-1 
5-2 
NM_021318 
Mus musculus 
four and a half LIM domains 5 (Fhl5) 
LIM-only protein ACT 
8 
8-1 
8-2 
10 10-1 
12 
12-1 
12-2 
A1 A1-1 NM_013637 Mus musculus protamine 1 (Prm1) 
A3 A3-1 NP_542368 Mus musculus non-metastatic cells 5 (Nme5) 
2 2-1 NM_009449 Mus musculus tubulin, alpha 3B (Tuba3b) 
4 4-1 NM_019706 Mus musculus ring finger protein 138 (Rnf138) 
13 13-2 NM_008211 Mus musculus H3 histone, family 3B (H3f3b) 
1   Transformation failure 
15   Sequencing analysis of failure 
21   Sequencing analysis of failure 
 
A total of 26 yeast colonies were isolated from a mouse adult testis cDNA library. Note that the number 
A1 yeast positive colony contained two different AD plasmids which coded NudeL and protamine whereas 
all other yeast colonies contained only one clone. 6 clones coded for NudeL, which is already known to 
interact with Lis1. 7 clones coded for Ranbp9, 4 clones coded the LIM-only protein ACT, and 3 clones 
coded the BRCA1-associated protein BRAP. Further single clones represented tubulin alpha 3B, protamine 
1, non-metastatic cells 5, ring finger protein 138, and histone H3B cDNA. Three clones were not able to 
be transformed into E·coli or did not produce any readable sequence for technical reasons. 
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First, the size of the DNA inserts in Ranbp9, ACT, BRAP and NudeL clones was 
determined by digestion with restriction enzymes followed by separation on agarose 
gels. The pACT-AD plasmid was found at the expected size of around 8.1kb and 
inserts were detected ranging in size between 3530bp and 564bp (Fig. 6a). Each 
individual clone started at different nucleotide positions compared to the reference 
sequence indicating that each identified cDNA clone represented a unique protein-
Lis1 interaction event (Fig. 6b).   
 
NudeL protein consists of 345 amino acids and the N-terminus of the protein (aa 
27-191) forms a typical coiled-coil structure that interacts with Lis1 protein (Toyo-
oka et al., 2003). Sequencing of the identified NudeL cDNA showed that most 
isolated clones contained the entire coding sequence and all included the coiled-coil 
region in agreement with previous data on Lis1 binding (Toyo-oka et al., 2003). 
 
Mouse Ranbp9 protein consists of 710 amino acids and contains four known 
structural domains referred to as SPRY (dual-specificity kinase splA and in 
ryanodine receptor), LisH (lissencephaly-1 like homology), CTLH (C-terminal to 
LisH), and CRA (or CT11-RanBPM) domains. All these motifs have been associated 
with protein-protein interactions (Murrin and Talbot, 2007). All but one of the 
isolated Ranbp9 cDNA clones included all of these domains. The single incomplete 
clone lacked the C-terminal CRA domain suggesting that this region is not essential 
for Lis1 binding. 
 
ACT protein consists of 285 amino acids and contains 4 and a half LIM domains. 
LIM domains are composed of double zinc-fingers that mediate protein-protein 
interactions (Dawid et al., 1998; reviewed in Curtiss and Heilig, 1998). All isolated 
ACT cDNA clones encoded the complete 4 LIM domains but one lacked the half LIM 
domain located at the N-terminus suggesting that this region of the protein was not 
important for binding to Lis1. 
 
Full length BRAP consists of 374 amino acids with three known domains referred to 
as Ring Finger, Znf-UBP, and Coiled-coil domain (Li et al., 1998). Interestingly, all 
identified BRAP cDNA clones only contained sequences encoding the coiled-coil 
domain. This coiled-coil domain shows no primary sequence homology to that of 
NudeL or Lis1. 
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C. LIM-only protein ACT
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Figure 6. Analysis of the clones obtained from yeast 2 hybrid screen using restriction 
digestions and multiple sequence alignments 
(a) The size of each individual insert of the Ranbp9, ACT, BRAP and NudeL clones was determined by 
digestion with EcoRI and XhoI restriction enzymes. The pACT2 plasmid has a size of 8.1Kb and the 
inserts ranged from 564bp to 3530bp according to the cDNA size of each clone. 
(b) To confirm the exact insert size of the plasmid DNA, clones were sequenced from 5’ and 3’ end sides. 
The Blast (bl2seq) program was used for the sequence alignments of the identified clones with an 
according reference sequences. Each individual clone initiated at different nucleotide position of the 
reference sequence shown by DNA sequence analysis. 
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To investigate whether Lis1 indeed interacted with Ranbp9, ACT, and BRAP, the 
clones containing the longest cDNA inserts (#18 for NudeL, aa 1-345; #6-2 for 
Ranbp9, aa 40-710; #5-1 for ACT, aa 41-285; and #17 for BRAP, aa 401-592) were 
selected and further analyzed.  
 
3. 1. 2. The verification of the protein-protein interaction in yeast  
 
To verify binding of Ranbp9, ACT, and BRAP proteins to Lis1, the candidate clones 
and several control plasmids were cotransformed into a yeast strain with 
auxotrophies for several amino acids (outlined in Fig. 7). As shown in the left panel 
of the figure, all used bait constructs grow in the control medium lacking 
tryptophan. The amino acid tryptophan was omitted from the medium to propagate 
the bait constructs as these constructs express the selection marker, Trp1. In 
contrast, under selection conditions (lacking adenine, histidine, tryptophan and 
leucine) cells could only grow when bait and prey protein interaction occurred to 
overcome the requirements for adenine and histidine, due to Ade2 and His3 makers 
(Fig. 7, right panel). 
 
Independent cotransformations of Lis1 and candidate clones demonstrated that Lis1 
indeed interacts with Ranbp9, ACT, and BRAP (Fig. 7, right panel #3). Lis1 also 
bound efficiently to NudeL as has been shown previously (Toyo-oka et al., 2003 and 
Fig. 7, right panel #2). The specificity of the interaction was confirmed by unrelated 
bait proteins, such as Lamin C and SV40 large T-antigen which failed to show any 
interactions (Fig. 7, right panels #5 and #6).  
 
In conclusion, the various cotransformation assays in yeast demonstrated that the 
proteins isolated from the yeast two-hybrid screen specifically associated with Lis1 
protein but not with other unrelated baits. 
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Figure 7. Verification of the Lis1-interacting clones on selection plates 
The interaction of Lis1 with Ranbp9, ACT, and BRAP was investigated using selection plates lacking 
adenine, histidine, tryptophan and leucine. The GAL4-DBD-Lis1 and the GAL4-AD fusion of novel Lis1 
candidate interaction partners were cotransformed into the yeast strain AH109 (#3). In a set of controls, 
the AD-psV40 served as an unrelated control GAL4 AD vector (#4) whereas NudeL used as a positive 
control (#2). To further investigate the specificity of interaction, the pLexA-Lamin was used as a non 
specific bait (#5-6). GAL4-AD fusion of novel Lis1 candidate interaction partners were cotransformed 
into the yeast strain L40 with pLexA-lamin (#6). Individual transformants and cotransformants 
respectively were plated on control medium lacking tryptophan and the selection medium lacking 
adenine, histidine, tryptophan and leucine. The cotransformants of Lis1 with NudeL as well as Ranbp9, 
ACT and BRAP (right panel, #2 and #3) grew on high stringency selection plates whereas the negative 
controls (right panel, #4, #5, and #6) were not able to grow under these conditions. 
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3. 2. Assessment of protein interactions between Lis1 and Ranbp9, ACT, 
or BRAP proteins in vitro 
 
Ranbp9, ACT, and BRAP were isolated from a mouse adult testis library as putative 
Lis1 interacting proteins. So far, these three proteins had not been identified as 
interaction partners of Lis1.  
 
Here, I present various experimental approaches to confirm the protein-protein 
interactions between Ranbp9, ACT, and BRAP with Lis1 as suspected from the yeast 
two-hybrid data described before. 
 
3. 2. 1. GST pull-down assays  
 
GST pull-down assays were performed using different length Lis1-glutathione-S-
transferase fusion proteins to probe for protein-protein interactions. Full length Lis1 
(aa 1-410) protein, the N-terminus of Lis1 (aa 1-95) containing the LisH and coiled-
coil domain, and the C-terminus of Lis1 (aa 96-410) containing the 7 WD-40 repeat 
domains were separately fused to GST. In this way, the protein binding region of 
Lis1 that is required for the association with other proteins could be determined. All 
hybrid proteins and native GST protein used as control were expressed in E. coli 
and purified on glutathione sepharose beads. The highly enriched recombinant 
proteins were checked on SDS-PAGE (Fig. 8B).  
GST-Lis1
GST-Lis1-N
GST          LisH   Coiled  7WD-40 repeats
GST-Lis1-C
A                                                               B
1           39 40        85 96                                  410
GST          LisH   Coiled
1                                   110
GST          7WD-40 repeats
110                                  410
G
S
T-
Li
s1
 
G
S
T 
G
S
T-
Li
s1
-N
G
S
T-
Li
s1
-C
75kDa
50kDa
37kDa
25kDa
75kDa
 
 
Figure 8. Expression and affinity purification of Lis1-GST fusion proteins  
A. Schematic illustration of full length Lis1 GST fusion protein and two truncated forms, one containing 
the N-terminal LisH and the coiled-coil domains (aa 1-110) and the other containing the C-terminus 
including the 7WD-40 repeats (aa 110-410).  
B. Purified fusion proteins (20ug) were separated on a 12% SDS-PAGE and stained with Coomassie 
brilliant blue. Lane1: GST (26kDa) Lane 2: GST-Lis1-N (38kDa) Lane 3: GST-Lis1-C (59kDa) Lane 4: 
GST-Lis1 (71kDa). Smaller bands may be due to protein degradation. 
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In a first experiment, full length Lis1 GST fusion protein was tested for its 
association with in vitro translated, radioactively labeled Ranbp9 (aa 40-710), ACT 
(aa 1-285), and BRAP (aa 1-374) proteins. As shown in Fig. 9, full length Lis1 binds 
efficiently to all three candidates. Control experiments with purified GST protein 
alone showed no binding confirming the specificity of these interactions. NudeL 
protein (aa 1-345) is known to interact with Lis1 and served as a positive control. 
These results lent further support to the idea that Lis1 interacts with the identified 
proteins also in the GST pull-down assay in vitro. 
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Figure 9. Lis1 binds to Ranbp9, ACT, and BRAP 
A. Schematic representation of the GST-Lis1 fusion protein. 
B. GST-Lis1 protein or GST protein were coupled to Glutathione-sepharose and used to pull-down in vitro 
translated [S35]-labeled NudeL, Ranbp9, ACT, and BRAP proteins. Bound proteins were separated by 
SDS-PAGE and visualized by autoradiography. Input shows 10% of the in vitro translated protein used in 
the binding experiment. The lower band of BRAP corresponds to a second translation product using a 
different start codon.  
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3. 2. 1. 1. The seven WD-40 repeats of Lis1 is necessary for the 
interaction with all candidate proteins 
 
To dissect the region of Lis1 that is responsible for the association with the binding 
partners, two truncated forms of Lis1 protein (GST-Lis1-N and GST-Lis1-C) were 
generated and used in pull-down assays. As shown in Figure 10, the C-terminus of 
Lis1 strongly interacted with Ranbp9, ACT, and BRAP proteins, whereas the N-
terminus of Lis1 (aa 1-110) failed to bind Ranbp9 and ACT proteins (Fig. 10B). In 
contrast, BRAP protein showed some binding to the Lis1 N-terminus which was, 
however, much weaker than the one observed with the Lis1 C-terminus. GST 
protein alone was unable to pull down any of the tested proteins, as observed 
previously. 
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Figure 10. The C-terminus of Lis1, 7WD-40 repeats binds Ranbp9, ACT, and BRAP proteins 
A. Schematic illustration of two truncated forms of Lis1 GST fusion proteins. 
B. Bound proteins were separated on SDS-PAGE followed by autoradiography. Note that all proteins are 
pulled-down efficiently by GST-Lis1-C. The protein can be recovered with GST protein alone and GST-
Lis1-N although BRAP showed a weak binding to the GST-Lis1-N. 10% of the vitro translated protein 
served as reference for input. 
 
 
 
Taken together the pull-down experiments with GST fusion proteins suggested that 
primarily the C-terminal 7 WD-40 repeat domains mediate interactions of Lis1 with 
Ranbp9, ACT, and BRAP. For BRAP binding, there appears to be an additional 
contribution of the Lis1 N-terminus. 
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3. 2. 2. Bimolecular Fluorescence Complementation (BiFC) assays 
confirm interaction of Lis1 with Ranbp9, ACT, and BRAP in tissue culture 
cells 
 
The bimolecular fluorescence complementation (BiFC) assay was performed to 
analyze the Lis1 protein interactions with Ranbp9, ACT, and BRAP in living cells. The 
principle of the method is based on a fluorescent reporter protein which has been 
split into two parts, the N-terminal and C-terminal fragments. Each of these 
separated protein fragments is unable to emit fluorescent light. However, when 
both fragments reassociate via fused protein domains (Fig. 11A), fluorescence can 
be reconstituted (Fig. 11B-C) (Morell et al., 2008). Intracellular signals can be 
detected by confocal microscopy which under certain circumstances allows to 
identify the cellular localization of the interacting proteins with high resolution. 
Moreover, fluorescence activated cell sorting (FACS) can be used to quantify protein 
interactions in a cell population. In this study, the YFP derivative Venus fluorophore 
(a kind gift of Dr. S. Illenberger) was utilized for the BiFC assay.  
 
 
A                                                         B     C
 
 
 
 
Figure 11. Principle of the bimolecular fluorescence complementation assay 
A. A bait protein is fused to the C-terminus of YFP fluorescence reporter protein (CYFP) and a prey 
protein is linked to the N-terminus of YFP (NYFP). 
B-C. When bait and prey interact, the YFP fluorescence reporter protein is reconstituted and is able to 
emit fluorescence upon activation with laser light of λ=488nm. (adapted in Morell et al., 2008) 
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In a first step, full length Lis1 (aa 1-410) and the identified Ranbp9 (aa 40-710), 
ACT (aa 1-285), and BRAP (aa 1-374) proteins were linked to the amino- and the 
carboxyl-terminal fragments of the Venus fluorophore, respectively, by molecular 
cloning (Fig. 12). Expression of these hybrid proteins in HeLa cells was confirmed 
on a Western blot using antibodies against Flag and HA protein tags that were part 
of the various constructs (data not shown).  
 
 
YFP aa155-238 HA Ranbp9, ACT, or BRAP
YFP aa1-154 Flag Lis1Venus-N
Venus-C YFP aa155-238 HA Lis1
YFP aa1-154 Flag Ranbp9, ACT, or BRAP
A                                                               B
 
 
 
Figure 12. Schematic representation of Venus fusion proteins 
cDNAs for Lis1 and all identified proteins were cloned into the multiple cloning sites of Venus-N and 
Venus-C vectors. Venus-N vector contains the N-terminus of Venus (aa 1-154) and can also be 
recognized by its Flag-tag. Venus-C consists aa 155-238 of the Venus fluorophore followed by an HA 
epitope tag.  
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3. 2. 2. 1. The detection of protein-protein interactions using confocal 
microscopy 
 
Combinations of the amino- and carboxyl-terminal portions of the Venus fusion 
proteins were transiently expressed in HeLa cells (Fig. 13). When only the amino 
and carboxyl parts of Venus fluorophore were expressed, no fluorescent cells could 
be detected (Fig. 13A). Clearly, the sole overexpression of both fluorophore 
fragments was not sufficient to reconstitute a stable and active structure of the 
Venus fluorophore. Likewise, combining Venus-N or Venus-C fragments alone with 
any of the Venus fusion proteins also did not generate fluorescent cells (Fig. 13 I 
and J). However, overexpression of the Venus-N-Lis1 with Venus-C-Lis1 enabling 
Lis1 homodimerization (Cahana et al., 2001) allowed the detection of strongly 
fluorescent HeLa cells (Fig. 13 B). Fig. 13 shows that the Lis1-dimers are 
exclusively present in the cytoplasm and spare the nucleus as described before 
(Cahana et al., 2001). These results provide good evidence for Lis1 interaction in 
HeLa cells detected by the bimolecular complementation assay of the Venus 
fluorophore. Moreover, using the lambda scanning ability of a Zeiss LSM confocal 
microscope, the maximum emission wavelength of the observed fluorescent signal 
was determined to be at λ=520-530, consistent with the reconstituted Venus signal 
(emission maximum at 528nm) (data not shown). Most interestingly, the 
coexpression of Venus-N-Lis1 and Venus-C-Ranbp9, Venus-C-ACT, and Venus-C-
BRAP in HeLa cells also generated fluorescent cells with similar absorption spectra 
(Fig. 13 C, E, and G). Comparable results were obtained when Venus-N-Ranbp9, 
Venus-N-ACT, and Venus-N-BRAP and Venus-C-Lis1 were coexpressed (Fig. 13 D, F, 
and H). The Lis1-Ranbp9 interaction signal was always detected in the cytoplasm 
suggesting the cytoplasmic localization of this protein-protein complex. The Lis1-
ACT protein interaction also seemed to occur predominantly in the cytoplasm of 
HeLa cells, although ACT alone is frequently found in the nucleus of spermatids 
(Fimia et al., 1999). Lis1-BRAP protein interaction was also mainly seen in the 
cytoplasm including some punctate signals in the perinuclear region.  
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Figure 13. Lis1 interaction with Ranbp9, ACT, and BRAP proteins in HeLa cells demonstrated 
by BiFC assay HeLa cells were transiently cotransfected with expression plasmids for Venus-N and 
Venus-C (A), and the indicated combination of Venus-N and Venus-C fusion proteins with Lis1 (B), 
Ranbp9 (C, D), ACT (E, F), and BRAP (G, H). Note the yellow YFP signals that the Venus fluorophore has 
been reconstituted by protein-protein interactions. Cells were analyzed by confocal microscopy. Blue 
nuclei were stained with DAPI. Background was determined in cells transfected with Venus-N-BRAP 
protein and Venus-C terminus or vice versa (I, J). 
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3. 2. 1. 2. Protein-protein interactions in cells were quantified by 
FACS analysis 
 
For better quantitative analysis, Venus fluorophore activation was measured by 
FACS analysis (Fig. 14). Fluorescence intensity and the cell size were determined 
and dots in the G1 quadrant indicated cells with protein-protein interactions. As 
expected, coexpression of amino- and carboxyl- termini of Venus showed 
essentially no protein interaction with background signals in about 0.6% of cells. In 
agreement with the results of the confocal microscopy, transient overexpression of 
Venus-N-Lis1 and Venus-C-Lis1 caused a significant number of cells (18.3%) to 
emit fluorescence. Coexpression of Venus-N-Ranbp9, Venus-N-ACT, and Venus-N-
BRAP together with Venus-C-Lis1 caused Venus fluorescence in 9.4% to 16.5 % of 
cells. In contrast, only few fluorescent cells were detected when the Venus-N-
Ranbp9, ACT, or BRAP fusion proteins were coexpressed with Venus-C alone used 
as negative control. 
 
In summary, these results provide first evidence that Lis1 is able to associate with 
Ranbp9, ACT and BRAP in living mammalian cells. The site of the formation of these 
stable complexes seemed to be predominantly in the cytoplasm.   
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Figure 14. Lis1-Ranbp9, ACT, or BRAP protein interaction demonstrated in HeLa cells by BiFC 
assay 
FSC (Forward scatter) is used to identify the cell size while the emitted Venus fluorescent signal was 
detected at 530nm (+/-10nm) using the FL1 (Fluorescent green light) channel. The G1 quadrant shows 
the percentage of the cells emitting YFP signals as a result of protein-protein interactions. 10,000 viable 
HeLa cells were analyzed by FACS. 
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3. 2. 3. Mutational analysis of individual binding domains in Lis1 
interacting proteins 
 
The previous experiments showed that the 7 WD-40 repeat domains of Lis1 were 
required for the association with Ranbp9, ACT, and BRAP. To identify the regions of 
Ranbp9, ACT, and BRAP that are essential for the interactions with Lis1, truncated 
versions of each of these proteins were used in various binding assays.  
 
3. 2. 3. 1. Ranbp9 binds to Lis1 via the SPRY domain 
 
First, the BiFC assay was performed with two truncated forms of Ranbp9, 
containing either aa 40-393 covering most of the amino terminus of Ranbp9 with 
the SPRY and LisH domains or aa 394-710 containing the CTLH and CRA domains. 
Either of these coding regions were fused to the carboxy-terminus of the Venus 
fluorophore. Expression levels of the fusion proteins in HeLa cells were determined 
on Western blots (Fig. 15A).  
 
The BiFC experiments showed that the N-terminal aa 40-393 of Ranbp9 protein are 
sufficient to mediate the interaction with Lis1, while the C-terminus failed to form 
complexes (Fig. 15). This suggests that the SPRY and/or the Lis1H domains are the 
key for the association with Lis1 protein. Apparently, the CTLH and the carboxyl-
terminal CRA domains of Ranbp9 are not required for the interaction. Interestingly, 
the isolated amino terminal part of Ranbp9 interacted significantly more efficient 
with Lis1 than the full length Ranbp9, based on the observed mean fluorescence 
intensity and the frequency of fluorescent cells (Fig. 15).  
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Figure 15. Lis1 binds to N-terminus of Ranbp9 protein 
A. Schematic illustration of the used Ranbp9 expression constructs all of which were fused to the 
carboxy terminal fragment of the Venus fluorophore. All constructs were expressed in HeLa cells and 
proteins expression was detected by Western blotting using HA antibody (right side).  
B-C. Interaction between Lis1 and Ranbp9 truncations were demonstrated by BiFC assay. HeLa cells 
were transiently cotransfected with indicated combination of Venus-N-Lis1 and Venus-C fusion proteins 
with Ranbp9, Ranbp9-N or Ranbp9-C. The cells emitting YFP signals as a result of protein-protein 
interactions were analyzed by FACS using the FL1 channel (B) and confocal microscopy (C).  
 
 
 
 
   
Results │ 66 
To obtain confirmation and to extend the finding that the N-terminus of Ranbp9 was 
required and sufficient to mediate the association with Lis1, co-immunoprecipitation 
(Co-IP) assays were performed. A set of Ranbp9 truncations was prepared by 
molecular cloning, all of which were fused to the HA epitope (Fig. 16). Similarly, 
Lis1 was tagged with Flag epitope. Overexpression of these constructs in HEK293T 
cells allowed to perform Co-IPs in which full length Lis1 protein was tested for the 
association with various fragments of Ranbp9 protein (Fig. 16A). The Co-IP 
experiments confirmed the previous results that Ranbp9-N terminus (aa 40-710) 
binds to Lis1 protein (Fig. 16B lane2). Moreover Lis1 coimmunoprecipitated with the 
SPRY+LisH containing fragment (aa 40-393) from transfected HEK293T cells, but 
not with the CTLH+CRA domains (aa 379-710) (Fig. 16B lane 3 and 4). These 
observations argue that only the amino terminal region of Ranbp9 is required for 
binding of Lis1. 
 
To elucidate which of the two potential binding domains, LisH or SPRY of Ranbp9 
mediates the interaction with Lis1, Co-IP assays were performed with appropriate 
expression constructs. As shown in Fig. 16C, the Co-IP experiments confirmed that 
the N-terminus of Ranbp9 associates with Lis1 protein. Interestingly, Lis1 
coimmunoprecipitated with the single SPRY domain but not with the LisH+CTLH 
suggesting that the SPRY domain of Ranbp9 alone is sufficient for binding. Moreover, 
this data indicates that both proteins do not interact via their LisH motifs.   
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Figure 16. Ranbp9 binds to Lis1 via the SPRY domain 
A. Schematic representation of Ranbp9 expression constructs which all were in frame with an amino-
terminal HA epitope. The expression of these Ranbp9 deletions in HEK293T cells was detected on 
Western blots using an HA antibody specific for the HA epitope.  
B-C. HEK293T cells were cotransfected with expression plasmids for Flag-Lis1 and HA-Ranbp9 
truncations. 24hrs after transfection, the cell lysates were subjected to immunoprecipitation with HA 
antibody. Protein interactions were analyzed by Western blots with Flag antibody. Input shows 10% 
sample of Flag-Lis1 protein used in the binding assay (B. Lane1). Lis1 was able to interact with Ranbp9 
and the N-terminal region (SPRY+LisH) (B. Lane 2 and 3; C. Lane 1 and 3) but not with the C-terminal 
region (CTLH+CRA) (B. Lane 4). Moreover, Lis1 bound to the SPRY domain (C. Lane 2), but not to the 
LisH+CTLH domains (C. Lane 4). A control experiment with Flag-Lis1 alone showed no signal 
demonstrating the specificity of this assay (B. Lane 5). 
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3. 2. 3. 2.  The 4 complete LIM domains of ACT are required for 
interaction with Lis1 
 
ACT contains four and a half LIM domains. The third LIM domain has been 
suggested to be important for interaction with CREM (Fimia et al., 1999), while all 
LIM domains are necessary for interaction with KIF17b (Kotaja et al., 2005). 
Interestingly, all ACT clones isolated in the yeast two-hybrid assay contained four 
intact LIM domains (aa 41-285), but lacked the half LIM domain. To further define 
the domains necessary for Lis1 binding, various mutant forms of ACT protein were 
tested in coimmunoprecipitation (Co-IP) assays with Lis1 protein. 
     
Truncated forms of ACT were fused to the HA epitope and transiently expressed in 
COS-7 or HEK 293T cells together with Lis1 tagged with the Flag epitope. The 
expression of all proteins was monitored by Western blotting (Fig. 17A).  
 
The Co-IP experiments verified the protein interaction of the four complete LIM 
domains of ACT excluding the half LIM domain (aa 41-285) with Lis1 protein (Fig. 
17B). Also, full length ACT (aa 1-285) coimmunoprecipitated with Lis1 from 
transfected HEK293T cell extracts. In contrast, none of the truncated LIM domain 
constructs was able to associate with Lis1 (Fig. 17C). This data suggests that all 
complete LIM domains of ACT are required for the interaction with Lis1, probably 
via the 7 WD-40 repeats. 
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Figure 17. The intact 1-4 Lim domains of ACT are required for interaction with Lis1 
A. Schematic illustration of ACT truncations. All ACT constructs were tagged with the HA epitope and 
expressed in COS-7 or HEK293T cells and the protein expression were detected on Western blots using 
HA specific antibody.  
B-D. COS-7 or HEK293T were cotransfected with different combination of Flag tagged Lis1 and HA 
tagged ACT truncations as indicated. 24hrs after transfection, the cell lysates were immunoprecipitated 
with HA antibody and immunoprecipitates were separated on SDS-PAGE and analyzed by 
immunoblotting with Flag antibody. 10% sample of Flag-Lis1 protein used in the binding assay was 
served as input (B-D. Lane1). Lis1 was sufficient to interact with the intact 4 LIM domains (B. Lane 3) 
and full length ACT protein (C-D. Lane 2). However a series of truncated forms of the LIM domains did 
not show any binding to Lis1 protein (C. Lane 3 and 4; D Lane 3, 4, and 5). A control experiment with 
either Flag-Lis1 or HA-ACT (derived from the yeast two-hybrid screen) alone did not illustrate any signals 
demonstrating the specificity of this assay (B. Lane 2 and 4; C. Lane 5; D. Lane 6). 
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3. 2. 3. 3. Complex formation of Lis1 and BRAP involves the coiled-coil 
domain of BRAP 
 
The full length BRAP (BRAP) protein contains 374 amino acids and three known 
distinct domains (Fig. 18A). Interestingly all BRAP clones isolated in the yeast two-
hybrid screen encoded only the carboxy-terminus of BRAP with the coiled-coil 
domain (Section in 3.1.1. Fig. 6D). Only one study so far described the C-terminal 
region of BRAP to be involved in the association with a binding partner (Asada et al., 
2004). Since the interaction of Lis1 with the coiled-coil domain of BRAP was already 
seen in yeast, it seemed very likely that only this BRAP domain was involved in Lis1 
binding. Similar to experiments described above for Ranbp9 and ACT, I investigated 
the Lis1 and BRAP association in COS-7 cells by Co-IP assays. First, the coiled-coil 
domain of BRAP (cBRAP) was fused to the HA epitope and its expression was 
confirmed on a Western blot (Fig. 18A). Co-expression of HA-cBRAP together with 
Flag-Lis1 revealed that the coiled-coil domain of BRAP alone was sufficient for 
interaction with Lis1 protein (Fig. 18C).   
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Figure 18. The C-terminal, Coiled coil domain, associates with Lis1 
A. Schematic illustration of the BRAP construct. Overexpressed HA tagged coiled-coil domain of BRAP 
was analyzed from COS-7 cell lysate by Western blot with a HA specific antibody. 
B. The expression plasmids for Flag-Lis1 and HA-cBRAP were coexpressed in COS-7 cells and 24hrs after 
transfection, the cell lysates were immunoprecipitated with HA antibody. Protein interactions were 
verified by Western blots with a Flag specific antibody. 10% input illustrates the sample of Flag-Lis1 
protein used in the binding assay (B. Lane1). The specificity of this assay was demonstrated by control 
experiment with either HA-cBRAP or Flag-Lis1 alone showing no signals (B. Lane 2 and 4).  
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Also a BiFC assay confirmed this result (Fig. 19). Lis1 and cBRAP proteins fused to 
Venus-N and Venus-C fragments, respectively, were transiently coexpressed in 
HeLa cells and produced fluorescent cells with an emission wavelength of λ=520-
530nm. Protein interaction was detected in the cytoplasm. Interestingly, punctate 
signals were also observed in the perinuclear region similar to the results obtained 
with the full length BRAP protein.  
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Figure 19. The interaction between Lis1 and Coiled-coil domain of BRAP was demonstrated by 
bimolecular fluorescence complementation assay. 
The indicated combination of Venus-N and Venus-C fusion proteins with Lis1 and cBRAP (B and D) were 
transiently coexpressed in HeLa cells and the reconstitution of Venus Fluorophore due to protein-protein 
interactions were analyzed by confocal microscopy. The specificity of interaction was verified in cells 
transfected with Venus-N terminus and Venus-C-cBRAP protein or vice versa (A and C). Nuclei were 
counterstained with DAPI (blue). 
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Taken together, these observations provide conclusive evidence that the coiled-coil 
domain of BRAP is sufficient for complex formation with Lis1. However, additional 
parts of BRAP are also able to bind to Lis1. The N-terminal region of BRAP 
possesses a conserved C2H2–type zinc finger motif that has been shown to be 
involved in binding to the nuclear localization signal (NLS) of BRCA1 (Li et al., 
1998). To explore the potential of the N-terminus of BRAP to also associate with 
Lis1, GST pull-down assays were performed. Fig. 20A shows that full length Lis1 
interacts with the N-terminus of BRAP including the zinc finer domains. This data 
suggests that BRAP binding to Lis1 involves at least two regions, the C-terminus 
and the N-terminus, which both can mediate the interaction independently. 
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Figure 20. The determination of BRAP domains for interaction with Lis1 
A. Schematic illustration of full length BRAP and two truncated forms. 
B. The interaction between Lis1 and BRAP truncations was analyzed by GST pull-down assay. Bound 
proteins and 10% input of in vitro translated protein were resolved on SDS-PAGE and followed by 
autoradiography. GST-Lis1 interacts with full length BRAP as well as the N- and the C-terminus of BRAP 
while GST protein alone did not show any interactions with BRAP.  
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3. 2. 4. Colocalization in mammalian cells  
 
3. 2. 4. 1. Cellular localization of Lis1 and Ranbp9 protein in HeLa 
cells 
 
The cellular localization of recombinant as well as endogenous Lis1 and Ranbp9, 
proteins were investigated by immunocytochemistry in HeLa cells (Fig. 21). 
Endogenous Lis1 was found throughout the cytoplasm with high concentration 
around the nucleus. This observation is in good agreement with previous studies of 
the cellular distribution of Lis1 protein (Assadi et al., 2003; Smith et al., 2000). 
Previous reports showed that endogenous Ranbp9 is mainly in the cytoplasm, 
although in cells of the immune system Ranbp9 also seems to localize to the 
plasma membrane (Denti et al., 2004). In addition, a truncated form of Ranbp9 
(called RanbpM) has been observed at the centrosome (Nakamura et al., 1998). HA 
tagged or endogenous Ranbp9 in HeLa cells were found by immunofluorescence 
exclusively in the cytoplasm and not in the nucleus or at the cell membrane of HeLa 
cells. Superimposition of stainings for Lis1 and Ranbp9 revealed that both proteins 
partially overlapped within the cytoplasm.                                                                                                                                                                                                                                                                                
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Figure 21. Cellular localization of recombinantly expressed and endogenous Lis1 and Ranbp9 
Overexpressed as well as endogenous Lis1 was found to partially associate with Ranbp9. 
A. To examine the distribution of overexpressed Lis1 and Ranbp9 proteins, HeLa cells cotransfected with 
Flag tagged Lis1 (green) and HA tagged Ranbp9 (red) were detected by Flag and HA specific-antibodies.  
B. Endogenous Lis1 (green) and Ranbp9 (red) proteins were detected by specific antibodies.  
In all figures, the nucleus was counter-stained with DAPI (blue). 
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3. 2. 4. 2. The subcellular localization of Lis1 and ACT protein in HeLa 
cells 
 
The subcellular distribution of Lis1 and ACT proteins was also studied in mammalian 
cells. Endogenous ACT protein is only expressed in testis during primary 
spermatogenesis. Therefore, overexpression studies with tagged forms of ACT were 
performed. HeLa cells were transiently transfected with eGFP tagged Lis1 (aa 1-
410) and HA tagged ACT (aa 1-285) and subsequently stained with HA-specific 
antibody. As expected, overexpression of Lis1 protein resulted in intense signals 
within the cytoplasm (Smith et al., 2000) (Fig. 22A) and overexpressed ACT protein 
was observed both, in the nucleus and the cytoplasm (Kotaja et al., 2005) (Fig. 
22B). This result demonstrates that both proteins when coexpressed in the same 
cell accumulate and partially colocalize in the cytoplasm, while ACT alone is also 
found in the nucleus (Fig. 22C). 
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Figure 22. Subcellular localization of Lis1 and ACT 
A. eGFP-Lis1 (green) was transfected into HeLa cells and over expressed protein was observed through 
the cytoplasm of HeLa cells.  
B. Overexpressed HA-ACT was detected in cytoplasm and nucleus. Localization of ACT protein was 
determined by HA antibody after HA-ACT transient transfection into HeLa cells. ACT (red) was detected 
in the cytoplasm and nucleus. 
C. Colocalization of Lis1 and ACT was predominately detected at the cell cortex. 
The nucleus was stained with DAPI (Blue). 
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3. 2. 4. 3. Lis1 protein colocalizes with BRAP in HeLa cells. 
 
The subcellular localization of BRAP protein in mammalian cells was also determined 
by immunocytochemistry. There is no available antibody for BRAP, therefore 
overexpression studies were performed with a tagged BRAP. HA tagged full length 
BRAP was expressed in HeLa cells and found in the cytoplasm in agreement with 
previous studies (Li et al., 1998) (Fig. 23A). When Lis1 and BRAP proteins were 
coexpressed in HeLa cells, both proteins displayed tightly overlapping expression 
domains (Fig. 23A). Occasionally, in about 5-10% of cells overexpressing BRAP, the 
protein was clustered close to the nucleus (Fig. 23B). 
 
endogeneous-Lis1                        HA-BRAP                               Merge
Flag-Lis1                                HA-BRAP                               Merge
A
B
 
Figure 23. Lis1 protein colocalize with full length of BRAP in the cytoplasm of HeLa cells 
A. Overexpressed Lis1 (green) and BRAP (red) were detected in the cytoplasm and seem to colocalize 
(yellow). Flag tagged Lis1 together with HA tagged BRAP were transiently transfected into HeLa cells. 
24hrs after transfection, cells were fixed and stained with HA and Flag specific antibodies.  
B. Endogenous Lis1 protein (green) was observed with overexpressed BRAP (red). Both proteins were 
localized predominantly in cytoplasm and more concentration of BRAP expression was sometimes 
detected at a point next to the nucleus. HA tagged BRAP were transiently transfected into HeLa cells. 
24hrs after transfection, the cells were fixed and stained with Lis1 and HA specific antibodies.  
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Since in previous experiments the coiled-coil domain of BRAP (cBRAP) showed 
interaction with Lis1, I investigated also its potential to colocalize with Lis1 in HeLa 
cells. HA-tagged cBRAP and Flag-tagged Lis1 were subjected to 
immunocytochemistry which revealed cBRAP protein expression in a punctate 
staining next to the nucleus overlapping with Lis1 protein (Fig. 24).  
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Figure 24. Lis1 protein colocalizes with cBRAP in HeLa cells  
To determine the localization of cBRAP and to exam the colocalization of Lis1-cBRAP, Flag-Lis1 and HA-
cBRAP were transiently transfected into HeLa cells. 24hrs after transfection, the cells were fixed and 
stained with antibodies.  
A. When cBRAP was overexpressed in cells, the protein expression was detected at a certain point next 
to the nucleus.  
B. Overexpressed Lis1 (green) and cBRAP (red) were detected mainly at a point near the nucleus where 
they seem to colocalize (yellow). 
 
 
This result suggests that the cluster-like accumulation of BRAP in the perinuclear 
region maybe mediated by the C-terminal coiled-coil domain, possibly in association 
with Lis1. To examine the BRAP staining next to the nucleus, an antibody to 
gamma-tubulin that specifically recognizes the centrosome was applied. 
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Lis1 is known to interact with the centrosome and may play an important role for 
positioning of the centrosome (Smith et al., 2000). BRCA-1, one of the BRAP 
interacting proteins, was also discussed for the activity of microtubule nucleation in 
the centrosome (Sankaran et al., 2005). Immunostaining revealed that neither full 
length BRAP (Fig. 25A) nor the coiled-coil domain of BRAP (Fig. 25B) costained with 
gamma-tubulin, indicating that BRAP is not part of the centrosome but may rather 
be associated with the Golgi complex.  
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Figure 25. Full length BRAP as well as coiled-coil domain of BRAP does not seem to colocalize 
with gamma tubulin in HeLa cells 
To exam the colocalization of full length BRAP or cBRAP and centrosome, HA-BRAP or HA-cBRAP was 
transiently transfected into HeLa cells. 24hrs after transfection, the cells were fixed and stained with 
specific antibodies for gamma tubulin and HA epitope.  
A. Full length BRAP (green) was localized in throughout the cytoplasm and not associated with gamma-
tubulin (yellow arrow indicates). 
B. When cBRAP was overexpressed in cells (white arrows indicate), protein expression was detected at 
certain points next to the nucleus but cBRAP did not colocalize with gamma-tubulin (indicated by the 
yellow arrow).  
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The Golgi complex is usually located close to the nucleus to perform vesicular 
transport mediated by dynein motor function along microtubules (Harada et al., 
1998; Presley et al., 1997). Lis1 protein has been shown to localize to the Golgi 
complex and different levels of Lis1 affect the cytoplasmic distribution of the Golgi 
complex (Nayernia et al., 2003; Smith et al., 2000). As illustrated in Fig. 26, the 
Golgi complex, visualized by a specific marker and eGFP-BRAP partially overlapped 
allowing the interpretation that BRAP protein may at least in some instances 
associates with Golgi structures. 
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Figure 26. BRAP associates with Golgi complex in the cytoplasm of HeLa cells  
To investigate the subcellular colocalization of full length BRAP (A) or coiled-coil domain of BRAP (B) and 
Golgi, HeLa cells were transiently transfected with either eGFP-BRAP or eGFP-cBRAP. Colocalization of 
eGFP-BRAP or eGFP-cBRAP (green) with a Golgi marker, BODIPY TR-ceramide (red), in living HeLa cells 
reveals that BRAP is partially overlapped with Golgi complex. 
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3. 2. 5. Analysis of Lis1, Ranbp9, ACT, and BRAP in testis 
 
To characterize mRNA expression of the Lis1 gene and its identified interacting 
partners in various mouse tissues including the testis, RT-PCR was performed. In 
agreement with previous studies, it was found that Lis1, Ranbp9, and BRAP are 
expressed in most of the mouse tissues but ACT is specifically confined to testis 
(Fig. 27) (Nishitani et al., 2001; Li et al., 1999; Fimia et al., 1999).  
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Figure 27. RT-PCR analysis in adult mouse tissues 
mRNA expression of Lis1, Ranbp9, and BRAP were detected in all mouse tissues whereas mRNA 
expression of ACT was observed only in testis. GAPDH transcripts served for as a control for the use of 
equal amounts of template. Total RNA from 12 different organs of adult mouse tissues was analyzed by 
RT-PCR. 
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I also analyzed testis RNA from different mouse mutants (a kind gift of Prof. W. 
Engel) that specifically arrest spermatogenesis at different stages (Fig. 28). Lis1, 
Ranbp9, and BRAP were expressed in testis of wild type and all mutant animals, 
except the one of the W/Wv mouse which lacks all spermatogenic cells (Rooij and 
Boer, 2003). This indicates that Lis1, Ranbp9, and BRAP transcripts are expressed 
throughout spermatogenesis. In contrast, ACT transcripts were only detected in 
mutants with defects in late spermatogenesis, such as the olt/olt and qk/qk strains 
but not in mutants that block early spermatogenesis (Fig. 28) (Bennett et al., 1971; 
Moutier, 1976). This result validates previous studies that ACT is specifically 
expressed during late stages of spermatogenesis (Fimia et al., 1999). It also shows 
that the Lis1 gene is active throughout spermatogenesis. Lis1 binding partners 
Ranbp9, ACT, and BRAP are expressed during over-lapping periods of 
spermatogenesis.  
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Figure 28. mRNA expression from testes in various mutants with defects of spermatogenesis  
Total RNA from mice testes of different mutants with defects in spermatogenesis was analyzed by RT-
PCR using specific primers for Lis1, Ranbp9, ACT, and BRAP. GAPDH gene expression served as a control. 
W/Wv mice are characterized by lack of any germ cell (Rooij and Boer,2003). Tfm/y and Leyl-/- mutants 
are arrested at the spermatocytes stage (Lyon and Hawkes, 1970; Zimmermann et al., 1999), while in 
olt/olt spermatogenesis stops at the round spermatids stage and in qk/qk at the elongated spermatids 
stage (Bennett et al., 1971; Moutier, 1976). Spermatogonium: SG; Spermatocytes: SC; Round 
spermatids: RS Left panel illustrate cross-section of a mouse seminiferous tubules (Adapted from Gilbert 
et al., 2003) 
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Next I determined the presence of the corresponding proteins in the adult wild type 
testis by immunohistochemistry. As illustrated in Fig. 29, Lis1 and Ranbp9 proteins 
were expressed in the cytoplasm of all types of spermatogenetic cells, but ACT was 
restricted to the late stages of spermatogenesis. Lis1 appeared to be enriched in 
spermatocytes and in elongated spermatids. Significant expression of Ranbp9 was 
observed in the cytoplasm of spermatocytes while expression levels of Ranbp9 in 
spermatogonia and spermatids were considerably lower. The double 
immunofluorescence reveals that Lis1 and Ranbp9 proteins are prominently 
coexpressed in the cytoplasm of spermatocytes and that Lis1 only colocalizes with 
ACT in late spermatogenetic cells. 
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Figure 29. Colocalization of Lis1 and Ranbp9 or ACT in mouse testis 
Double immunofluorescence staining was performed on mouse testis sections using specific antibodies 
for Lis1, Ranbp9, and ACT. Lis1 and Ranbp9 proteins are present in all spermatogenetic cells and a 
significant expression of both proteins is detected in the cytoplasm of spermatocytes (A). ACT protein is 
only found in the late stages of spermatogenic cells where ACT overlaps with Lis1 (B). Nuclei were 
counterstained with DAPI (Blue). 
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3. 3. Functional analysis of Lis1 in genetically manipulated cells 
 
3. 3. 1. Generation of immortalized mouse embryonic fibroblast (MEF) 
cells from mice carrying a floxed Lis1 allele 
 
To investigate the cellular function of Lis1 in more detail, immortalized mouse 
embryo fibroblasts (MEFs) were generated from E13.5 wild type, Lis1wt/flox, and 
Lis1flox/flox mouse embryos. The mouse mutant was generously provided by Dr. 
Wynshaw-Boris A (University of California, USA). The murine Lis1 gene contains 11 
exons. Lis1flox/flox MEFs have two loxP sites inserted in Lis1 introns 3 and 7 to allow 
CRE mediated excision of exons 4 and 7 (Fig. 30A) (Hirotsune et al., 1998). CRE 
mediated deletion of both loxP alleles in vivo results in early embryonic lethality 
soon after implantation during embryogenesis (Hirotsune et al., 1998). 
Heterozygous Lis1 mutant mice are viable but display morphological abnormalities 
in the brain including the cortex, hippocampus, and olfactory bulb (Hirotsune et al., 
1998). Allele-specific PCR confirmed the genotypes of the established MEF lines (Fig. 
30B). All established MEF cells were polyclonal and showed similar growth behavior 
in culture. 
 
For CRE recombinase mediated site-specific recombination, wild type, Lis1wt/flox, and 
Lis1flox/flox MEFs were either transiently transfected with an expression plasmid 
encoding CRE recombinase tagged with fluorescent eGFP (hereafter eGFP-CRE) or 
infected with recombinant adenovirus expressing CRE recombinase and GFP to 
visualize CRE expressing cells (hereafter termed AD-CRE). Gene recombination was 
observed in Lis1wt/ΔLis1 and Lis1ΔLis1/ΔLis1 MEFs at various time points following CRE 
expression but not in Lis1 wild type MEFs, as determined by PCR analysis (Fig. 30C).  
 
While the expression of CRE recombinase in wild type MEFs had no effect on growth 
behavior (data not shown), heterozygous and homozygous Lis1-deficient cells grew 
fairly normal for 48 to 72 hours after transfection or infection but after that time 
period showed severe morphological changes, such as blebbing,  rounding up, and 
eventually cell death. These observations indicate that Lis1 is essential for long 
term survival of cells, although the used experimental system allowed to study 
short term effects of Lis1 deficiency for approximately 3 days in culture.  
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Figure 30. Analysis of Lis1 mutant mouse embryo fibroblasts (MEFs)  
A. Schematic representation of the Lis1 allele present in the mouse mutant used to isolate MEFs. Note 
the two loxP sites located in introns 3 and 7. Primers for PCR genotyping are indicated.  
B. Representative results of PCR genotyping from genomic DNA of wild type, Lis1wt/flox, and Lis1flox/flox 
MEFs. Diagnostic fragments for Wild type (167bp) and mutant (220bp) alleles are indicated.  
C. PCR analysis of recombined floxed Lis1 alleles (578bp) 24, 48, and 72hrs after infection of MEFs with 
CRE recombinase. 
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3. 3. 2. CRE recombinase decreases Lis1 protein levels in MEFs 
 
To ensure that Lis1 protein levels in MEFs are reduced after deletion of the Lis1 
gene, Western blot analysis and immunofluorescence staining of cultured cells was 
performed. Protein extracts from wild type, Lis1wt/ΔLis1 and Lis1ΔLis1/ΔLis1 MEFs on 
Western blot showed substantial reduction of Lis1 protein, while actin levels used as 
control remained unchanged (Fig. 31A and C). Reduction of Lis1 protein in 
heterozygous and homozygous Lis1-deficient MEFs compared to wild type cells was 
confirmed by immunofluorescence analysis. While Lis1 protein in wild type cells 
appeared throughout the cytoplasm, only residual Lis1 protein was found in 
heterozygous and homozygous mutant MEFs around the nucleus but not in 
peripheral regions of the cytoplasm (Fig. 31B and D). Similar results were obtained 
in MEFS transfected with CRE-recombinase expressing plasmid and with adenoviral 
mediated expression of CRE recombinase.  
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Figure 31. Accumulation of Lis1 protein in mutant MEFs after CRE recombinase mediated Lis1 
gene deletion 
MEFs were either transiently transfected with eGFP-CRE (A, B) or infected with AD-CRE (C, D). Cells 
were analyzed 48 and 72hrs after transfection and infection, respectively. 
A, C. Western blot of protein extract (10µg total protein) from wild type, Lis1wt/flox and Lis1flox/flox MEFs 
probed with an -Lis1 specific monoclonal antibody.  Gel loading was controlled with an actin specific 
antibody. 
B, D. Immunofluorescence analysis of MEFs illustrates reduction of Lis1 protein and distribution of 
residual Lis1 in the perinuclear region. Lis1 protein is shown in red (a, c, e) and GFP is indicated in green 
(b, d, f). Dotted lines were drawn to illustrate the outer margin of cells. The nucleus was stained with 
DAPI (blue) 
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3. 3. 3. Reduced levels of Lis1 may affect the steady state levels of 
Ranbp9 protein 
 
Ranbp9 may play a role as a scaffolding protein during various cellular processes 
(reviewed in Murrin and Talbot, 2007). A recent study demonstrated that Ranbp9 
controls cell morphology and may be involved in the exchange process between the 
cytoplasm and the nucleus (Valiyaveettil et al., 2008).  
 
Based on the previously demonstrated interaction of Ranbp9 with Lis1, I here 
wanted to investigate whether Lis1 affects the accumulation and distribution of 
Ranbp9 protein. To this end, immunofluorescence staining of cultured cells was 
performed. In heterozygous and homozygous Lis1-deficient MEFs, differentially 
distributed Ranbp9 protein compared to wild type cells was observed by 
immunofluorescence analysis. Ranbp9 protein was located throughout the 
cytoplasm in wild type cells, whereas in heterozygous and homozygous mutant 
MEFs reduced levels of Ranbp9 were found mainly in the perinuclear region and 
possibly also in the nucleus (Fig. 32A and C). Similar results were obtained for 
overexpressed HA-tagged Ranbp9 and the endogenous Ranbp9 protein.  
 
To control that the reduction of Ranbp9 protein was actually depended on the loss 
of Lis1 due to CRE recombinase, Lis1wt/flox, and Lis1flox/flox MEFs were tested. These 
cells exhibited no apparent difference in Ranbp9 protein without CRE-recombinase 
indicating that the amount of Ranbp9 is only reduced in cells with low levels of Lis1. 
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Figure 32. Low expression of Lis1 affects the level of Ranbp9 protein 
A. Immunofluorescence staining displays an altered distribution of recombinant HA-Ranbp9 in MEFS with 
variable amounts of Lis1 48hrs after transfection with eGFP-CRE. Note that the Ranbp9 levels are 
significantly reduced in Lis1wt/ΔLis1 and Lis1ΔLis1/ΔLis1 MEFs, where Ranbp9 can not be detected at the cell 
cortex. Localization of Ranbp9 protein (red) was done with an HA antibody while eGFP-CRE is 
indicated in green. The nucleus was counterstained with DAPI (blue).  
B. Lis1wt/flox and Lis1flox/flox control MEFs that do not express the CRE-recombinase show no alterations in 
the cellular levels and distribution of HA-Ranbp9.  
C. Endogenous Ranbp9 (red) was detected in wild type and mutant MEFs 72hrs after infection with AD-
CRE (green). Similar to the transfection experiments shown in Panel A, the levels of Ranbp9 protein were 
drastically reduced in Lis1wt/ΔLis1 and Lis1ΔLis1/ΔLis1 as compared to wild type MEFs and were completely 
depleted from the cell periphery. The dotted lines in A and C indicate the outer margin of the cells. 
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3. 3. 4. The microtubular cytoskeleton in Lis1-deficient cells  
 
Microtubules contribute essentially to the cellular architecture and cytoskeletal 
functions, such as vesicular transport, cell division, and cell migration. Lis1 directly 
interacts with microtubules and influences microtubule dynamics (Sapir et al., 
1997).  
 
Therefore, I investigated microtubules in Lis1-deficient cells by Western blot and 
immunocytochemical analysis using an -tubulin-specific antibody. While, protein 
extracts from wild type, Lis1wt/ΔLis1 and Lis1ΔLis1/ΔLis1 MEFs revealed no significant 
effects on the concentration of -tubulin protein on Western blots (Fig. 33A), the 
regional distribution of -tubulin in heterozygous and homozygous Lis1-deficient 
cells appeared somewhat altered compared to wild type cells (Fig. 33B). In MEFs 
with reduced levels of Lis1, the microtubular network determined by -tubulin 
stainings seemed less complex at the periphery of the cytoplasm. This observation 
demonstrated that loss of Lis1 might affect the microtubule network, in agreement 
with previous studies (Sapir et al., 1997; Smith et al., 2000; Yingling et al., 2008).  
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Figure 33. Determination of -tubulin in Lis1 mutant MEF cells  
72hrs after infection with AD-CRE. 
A. Western blot of protein extracts (10µg total protein) from wild type and Lis1 mutant MEFs reveals no 
significant alteration of levels of -tubulin expression. Gel loading was controlled with an -actin specific 
antibody.  
B. Immunofluorescence analysis of the distribution of -tubulin shows that the complexity of the 
microtubular network was reduced at the edge of the cytoplasm in Lis1 mutants. All scale bars 
correspond to 20µm. 
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3. 3. 5. Lis1 possibly contributes to stabilize microtubules 
 
There are a number of post-translational modifications of microtubules including 
phosphorylation of -tubulin, carboxy-terminal tyrosination and acetylation of -
tubulin as well as polymodifications including glycylation and glutamylation (Barra 
et al., 1974; L’Hernault and Rosenbaum, 1985; Eipper, 1972; Sandoval and 
Cuatrecasas, 1976; Gard and Kirschner, 1985; Verhey and Gaertig, 2007; 
Westermann and Weber, 2003). It is known that these modification of tubulin 
influence the interaction with microtubule-associated proteins, such as plus-end 
tracking proteins suggesting that such modifications play an important role in the 
regulation of properties and functions of the cytoskeleton (reviewed in Hammond, 
Cai and J. Verhey, 2008). Acetylation of -tubulin occurs at lysine 40 and 
constitutes a maker for stabilized microtubules, since it is only found in long-lived 
microtubules (Westermann and Weber, 2003). Recent studies suggest that 
acetylated tubulins play also a role in motor-based microtubule trafficking (Reed et 
al., 2006; Bulinski, 2007; Dompierre et al., 2007).  
 
To examine the influence of Lis1 on the level and distribution of acetylated tubulin, 
Western blot and immunofluorescence stainings were performed in cultured cells 
with variable concentrations of Lis1. Protein extracts from Lis1wt/ΔLis1, and 
Lis1ΔLis1/ΔLis1 MEFs revealed significantly reduced levels of acetylated tubulins as 
compared to wild type controls (Fig. 34A). In agreement with this finding, a 
reduction of acetylated tubulins was also identified by immunofluorescence analysis 
(Fig. 34B). Specifically, acetylated tubulin in heterozygous and homozygous Lis1-
deficient cells failed to extend to the cell cortex and appeared more sparse at the 
cell periphery in comparison to wild type cells. 
 
The relative reduction of acetylated tubulin in the outer cytoplasmic regions of Lis1-
depleted cells argues for a loss of stable microtubules supporting the view that in 
wild type cells Lis1 might possess a stabilizing influence on the microtubular 
network. 
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Figure 34. Reduced levels of Lis1 affect the distribution of acetylated tubulin in the cytoplasm 
A. Protein extracts (10µg total protein) from wild type, Lis1wt/ΔLis1, and Lis1ΔLis1/ΔLis1 MEFs were analyzed 
by Western blot. Reduced levels of acetylated tubulin were detected in Lis1wt/ΔLis1 and Lis1ΔLis1/ΔLis1 MEFs. 
Gel loading was controlled by actin protein detection. 
B. Immunofluorescence analysis of the distribution of acetylated tubulin in wild type and mutant MEFs. 
Note the diminished acetylated tubulin at the cell periphery when Lis1 levels are reduced. Scale bars: 20 
µm. All MEFs were analyzed 72hrs after AD-CRE infections. 
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3. 3. 6. Analysis of MT plus-end binding proteins in Lis1-deficient cells 
 
Microtubular dynamics are believed to be regulated by plus-end binding proteins. 
Lis1 has been implicated to play a role in microtubule plus-end capturing and 
stabilization through its interaction with plus-end binding proteins, such as CLIP-
170 and p150Glued, a subunit of dynactin. Structurally, CLIP-170 consists of a coiled-
coil domain that separates the microtubule binding region located at its N-terminus 
from a C-terminus metal binding motif which has been shown to associate with Lis1 
and dynactin (Diamantopoulos et al., 1999). CLIP-115 is structurally closely related 
to CLIP-170, although it lacks the C-terminal metal binding motif (De Zeeuw et al., 
1997). CLIP-115 is specifically expressed in brain and in early embryonic stages 
during development (De Zeeuw et al., 1997). Haploinsufficiency of CLIP-115 leads 
to Williams Syndrome in humans, a disorder of neural development. Therefore, 
CLIP-115 may be involved in neurodevelopmental processes (Hoogenraad et al., 
2002). Interestingly, absence of CLIP-115 leads to increased levels of CLIP-170 and 
dynactin at the tip of growing microtubules suggesting that CLIP-115 may regulate 
dynein motor functions along the microtubules (Hoogenraad et al., 2002; 
Lansbergen et al., 2004). 
 
In light of these informations, I examined the distribution of the microtubule plus-
end binding proteins, CLIP-170 and CLIP-115 in Lis1-deficient cells. 
Immunofluorescence staining on wild type, heterozygous, and homozygous Lis1-
deficient MEFs with a CLIP-170 specific antibody revealed no major differences 
between wild type and Lis1 mutant MEFs (Fig. 35A). To measure microtubule 
polymerization dynamics, such as growth and shortening rate (Komarova et al., 
2009; Perez et al., 1999) the average tail length of CLIP-170 comets at the 
microtubule plus-end was determined in wild type (380 microtubule ends in 12cells), 
Lis1wt/ΔLis1 (n=339; 11 cells), and Lis1ΔLis1/ΔLis1 (n=442; 11 cells) MEFs using the NIH 
ImageJ program (ImageJ 1.42q). No evidence for significant alterations in CLIP-170 
tail length at the end of growing microtubules was observed between wild type 
(2.38 ±  0.16µm; mean ±  standard deviation), Lis1wt/ΔLis1 (2.12 ±  0.11µm) and 
Lis1ΔLis1/ΔLis1 (2.26 ±  0.12µm) MEFs (Fig. 35B). 
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In contrast to CLIP-170, immunostaining for CLIP-115 demonstrated apparently 
longer comet tails of CLIP-115 end-decorations in heterozygous and homozygous 
Lis1-deficient cells as compared to wild type controls (Fig. 36A). For quantitative 
analysis, over 1000 individual comet tails of growing microtubules were measured 
from wild type (n=1351; 16 cells), Lis1wt/ΔLis1 (n=1163; 9 cells), and Lis1ΔLis1/ΔLis1 
(n=1483; 15 cells) MEFs. Significantly longer comet tail lengths were detected in 
Lis1wt/ΔLis1 (2.7 ±  0.13µm) and Lis1ΔLis1/ΔLis1 (3.51 ±  0.28µm) MEFs than in wild type 
MEFs (1.25 ±  0.09µm) (Fig. 36B). To evaluate the total protein levels of CLIP-115 
in the absence of Lis1, Western blot was performed with a specific CLIP-115 
antibody. Interestingly, the overall cellular concentration of CLIP-115 was not 
altered in Lis1-deficient cells suggesting that most likely kinetic parameters rather 
than stochiometry explains the altered CLIP-115 decoration (Fig. 37). MEFs with 
reduced Lis1 contained also fairly normal levels of p150Glued, a finding that is in 
agreement with previously described data (Fig. 37) (Smith et al., 2000). 
 
In summary, the decoration of growing microtubule plus-ends with CLIP-115 
appears modified in the absence of Lis1, although a direct interaction between both 
proteins has not been shown. 
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Figure 35. CLIP-170 is distributed similarly in cells with and without Lis1 protein  
MEFs infected with AD-CRE were analyzed 72hrs after infections.  
A. Immunofluorescence image from wild, Lis1wt/ΔLis1, and Lis1ΔLis1/ΔLis1 MEFs showed that the cytoplasmic 
distribution of CLIP-170 is not altered in Lis1 mutant and wild type MEFs. Scale bars: 20 µm. 
B. Measuring the average comet tail length of CLIP-170 at microtubule plus-ends confirms that there is 
no significant difference between the experimental groups. The error bars represent the standard 
deviation. 
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Figure 36. Low levels of Lis1 cause accumulation of CLIP-115 at the microtubule plus-end 
MEFs were infected with AD-CRE and analyzed 72hrs after infections. 
A. Immunofluorescence images demonstrating the altered cellular distribution of CLIP-115 in wild and 
Lis1 mutant MEFs. Scale bars: 10 µm. 
B. Quantitative analysis of the comet tail length of CLIP-115 indicates an elongated comet tail length in 
Lis1 mutant MEFs. The n represents the total number of measured microtubular tips and the error bars 
indicate the standard deviation.  
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Figure 37. No significant changes in the protein levels of the plus-end binding proteins, 
p150glued and CLIP-115, in Lis1 mutant cells  
Protein (10µg total protein) form wild type, Lis1wt/ΔLis1, and Lis1ΔLis1/ΔLis1 MEFs was analyzed by Western 
blots with specific antibodies. Significantly reduced protein expression levels of Lis1 were detected in 
Lis1 mutant compared with wild type MEFs. In contrast, the protein levels of p150glued and CLIP-115 were 
not significantly altered. Actin was served as loading control. For this experiment MEFs were infected 
with AD-CRE and analyzed 72hrs later. 
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3. 3. 7. The growth rate of microtubules appears influenced by Lis1  
 
End binding 1 (EB1) protein is one of the growing microtubular tip binding proteins 
that have been suggested to regulate microtubule dynamics by stimulating growth 
at microtubule plus-ends (Vitre et al., 2008; reviewed in Vaughan, 2005). Dynactin, 
one of the Lis1 interacting proteins, directly binds to EB1 and this complex might 
play a role in the elongation of microtubules (Strickland et al., 2005; Askham et al., 
2002). Lis1 usually colocalizes with EB1 at the plus-end tips of microtubules but 
EB1 is also known to exhibit a strong association with the centrosome (Caspi et al., 
2003). However, the precise relationship between Lis1 and EB1 remains unclear.  
 
To investigate whether Lis1 may play a role in the distribution of EB1, 
immunofluorescence staining of cultured cells with variable amounts of Lis1 was 
performed. As illustrated in Fig. 38, loss of Lis1 in heterozygous and homozygous 
MEFs had no effect on EB1, which, as expected, was specifically localized at the 
growing plus-ends of microtubules.  
 
Next, fluorescently tagged EB1 was introduced into wild type and mutant MEFS to 
evaluate the growth rate of microtubules as reflected by the speed of the 
movement of the growing plus-end (Bieling et al., 2008; Binker et al., 2007). The 
apparent movement of the GFP label was documented by time-lapse images that 
were taken in 4 second intervals during a 5 minute observation period. These 
results were hereafter statistically evaluated (105 microtubular ends in 8 wild type 
and 75 ends in 5 Lis1flox/flox mutant MEFs) using the Metamorph image analysis 
software. The results indicated that the rate of plus-end growth is markedly 
decreased in cells lacking Lis1 with only 6.4 ±  1.09µm/min (mean ±  standard 
deviation) in Lis1 depleted compared to 10.2 ± 1.78µm/min in wild type cells (Fig. 
39B and C). This observation in Lis1-deficient cells together with the evidence for 
longer CLIP-115 tails at the plus-ends of microtubules strongly argues that Lis1 
plays a role in controlling the speed of microtubular growth. It is unclear how this 
observation relates to the documented role of Lis1 in preventing catastrophic 
breakdown of microtubules. 
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Figure 38. EB1 localization is unaffected by levels of Lis1  
MEFs were analyzed 72hrs after infections with AD-CRE. The immunofluorescence detection of 
endogenous EB1 illustrates no significant differences in the distribution and the level of the plus-end 
binding protein between wild type (A) and Lis1 mutant MEFs (B, C). The left panel shows EB1 localization 
in an entire cell while the right panel represents the indicated detail of cell periphery. Scale bars: 20 µm. 
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Figure 39. Lis1 affects microtubule growth speed  
A. Western blot of protein extracts (10µg total protein) form wild type and Lis1 Lis1ΔLis1/ΔLis1 MEFs 24hrs 
after transfection of mCherry-CRE, reveal decreased levels of Lis1 protein in Lis1ΔLis1/ΔLis1 MEFs compared 
with wild type. Actin was used to monitor gel loading. 
B. Representative time-lapse images of wild type and Lis1ΔLis1/ΔLis1 MEFs transiently expressing GFP-EB1. 
The arrows indicate a single plus-end tip as visualized by GFP-EB1 signal that is followed in wild type and 
mutant MEFs during the indicated time frame. This allowed the precise determination of the microtubular 
growth rate. 
C. Quantitative analysis of the speed of growing MT shows that the MT growth speeds in Lis1-deficient 
cells (6.4 ±  1.78µm/min) are slower than wild type (10.2 ±  1.09µm/min). The error bars represent the 
standard deviation of repeated measurement, the n of which is indicated. The statistical significance 
(***, P<0.001) was determined by t-test. For all experiments shown in panels B and C, MEFs were 
analyzed 24hrs after transfection with GFP-EB1 and mCherry-CRE. Double-positive cells were imaged at 
4s intervals during 5mins using suitable video microscopy (Zeiss). The growth speed of microtubules was 
analyzed by Metamorph program.  
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4. Discussion 
 
Mutations in the Lis1 gene have been reported to be responsible for type I 
lissencephaly. Numerous studies were performed to investigate the molecular 
functions of Lis1. From these investigations, it becomes clear that Lis1 plays a role 
as subunit of the PAF-AH complex that regulates the activity of PAF (Reiner et al., 
1993). PAF is a potent phospholipid that regulates various physiological processes, 
particularly in the central nervous system and reproductive organs (Roudebush, 
2001; Hattori et al., 1994; Umemura e tal., 2007). In addition, Lis1 interacts with 
the cytoskeleton and seems to regulate microtubule dynamics. These microtubule-
associated roles include mitotic and meiotic cell division, nuclear migration, 
vesicular transport, and neuronal migration (Sapir et al., 1997; Smith et al., 2000; 
Sasaki et al., 2000).  
  
Lis1 protein in testis appears to be required for proper germ cell development as 
Lis1 mutant males are infertile and show defects in spermatogenesis (Nayernia et 
al., 2003). Here, I describe the approach to investigate further details of the 
functional role of Lis1 during spermatogenesis. Screening of an adult mouse testis 
cDNA library by the yeast two-hybrid assay identified three novel candidate proteins 
that can bind to Lis1 protein. These include Ranbp9 (Ran binding protein 9), ACT 
(activator of CREM in testis), and BRAP (BRCA1 associated protein) that interact 
with Lis1 similar to the known binding partner NudeL. 
  
The present study demonstrates by different methods and techniques physical 
interactions between Lis1 and Ranbp9, ACT, or BRAP. Moreover, it shows that the 7 
WD-40 repeat motifs of Lis1 mediate the interactions with Ranbp9, ACT, and BRAP. 
Interestingly, the 7 WD-40 repeat motifs of Lis1 are known to be involved in a 
variety of protein-protein interactions and cellular functions including signal 
transduction, cytoskeleton regulation, and regulation of vesicular transports 
(reviewed in Li and Roberts, 2001). 
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Possible roles of Ranbp9 in its cytoplasmic association with Lis1 
 
Ranbp9 protein constitutes a novel Lis1 binding protein that interacts with Lis1 via 
its SPRY domain. Interestingly, the Lis1 homology motif that is also present Ranbp9, 
does not mediate interaction with Lis1. I find Ranbp9 predominantly in the 
cytoplasm, in good agreement with previous studies (Nishitani et al., 2001). 
Confocal microscopy and bimolecular complementation assays in mammalian tissue 
culture cells indicate that Lis1 and Ranbp9 can associate in the cytoplasm and 
reduction of Lis1 levels result in depletion of Ranbp9, most notably in the cell 
periphery. 
 
My observations suggest that Ranbp9 in association with Lis1 may be linked to the 
cytoskeleton. Although the relationship of Ranbp9 and microtubules is not known, 
recent studies on Ran binding proteins, including Ranbp9, provide arguments for 
such an association. 
 
Ranbp9 was originally identified as one of several proteins that bind to the small 
GTPase Ran, a key molecule involved in unclear transport of macromolecules 
(Nakamura et al., 1998). Ran also plays a role in the assembly of the spindle 
complex in mitotic cells (Kalab et al., 1999; Kahana and Cleveland, 1999). Recent 
data suggests that Ran may also be involved in axonal transport in postmitotic 
neurons (reviewed in Yudin and Fainzilber, 2009). 
 
The evolutionary conserved Ranbp1 in yeast cells (termed yrb1) is essential for the 
correct alignment of mitotic spindles (Ouspenski, 1998). In mammalian cells, 
Ranbp1 was shown in vivo to be part of mitosis (Guarguaglini et al., 2000). 
Furthermore, RanbpM, a truncated form of Ranbp9, was initially described in the 
centrosome of human lung fibroblasts (MRC-5), where it may control microtubular 
dynamics (Nakamura et al., 1998). In Xenopus laevis, members of the family of 
Ran binding proteins control mitosis (Carazo-Salas et al., 1999; Wilde and Zheng, 
1999). Taken together the various reports, it seems likely that Ran and its binding 
partners, Ranbps, may be associated with the cytoskeleton. 
 
This view is supported by my own investigations demonstrating that Ranbp9 binds 
to the microtubule-associated protein Lis1. 
 
   
Discussion │ 105 
The newly identified Ranbp10 protein, a close relative of Ranbp9, interacts with -
tubulin via its N-terminus (Schulze et al., 2008). Interestingly, both Ranbp9 and 
Ranbp10 share homology with guanine nucleotide exchange factors (GEFs), in 
particular with Rho-GEF. Usually, small GTPase, like Ran, display weak nucleotide 
exchange activity that is significantly enhanced by specific GEFs. The only known 
Ran-GEF factor so far is the nuclear protein Rcc1 (Schulze et al., 2008). However, it 
was demonstrated recently that Ranbp10 is also able to mediate the exchange of 
GDP for GTP in the Ran protein (Schulze et al., 2008). It is therefore tempting to 
speculate that Ranbp9 protein on microtubules may also exert GEF activity.  
 
 
The transcriptional regulator ACT forms complexes with Lis1 in the 
cytoplasm of spermatogenic cells in testis  
 
Lis1 is abundantly expressed in testis and particularly enriched in meiotically 
dividing spermatocytes and elongating spermatids (Koizumi et al., 2003). Male Lis1 
mutant mice with a homozygous gene trap integration in the Lis1 locus (Lis1GT/GT) 
are infertile and display severe defects in spermatogenesis suggesting that Lis1 is 
essential for male germ cell development (Nayernia et al., 2003). 
 
Here, I discovered that the germ cell specific transcription factor ACT binds to Lis1 
in a yeast two-hybrid assay. ACT regulates the process of male germ cell 
differentiation by interacting with CREM, a key factor for the regulation of numerous 
postmeiotic genes during spermatid maturation (De Cesare et al., 2003). ACT 
expression is restricted to late spermatogenetic cells (Fimia et al., 1999). A 
homozygous deletion of the ACT gene results in drastic oligozoospermia, although 
testis development in ACT-deficient mice appears normal. This data suggests that 
ACT is involved in regulating genes for structural components of mature sperm 
(Kotaja et al., 2004). 
 
The Lis1 gene trap integration described previously (Nayernia et al., 2003) affects 
nuclear condensation, formation of the tail structure, and development of the 
acrosome in spermatids. This phenotype is similar to ACT null mice which produce 
spermatids with abnormal nuclear condensation, vacuoles, defects in acrosome 
organization, and folded tails (Nayernia et al., 2003; Kotaja et al., 2004) suggesting 
that both, Lis1 and ACT, may have functions in overlapping processes during late 
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spermatogenesis. This hypothesis is actually supported by my observation that ACT 
and Lis1 are able to form complexes. 
 
ACT is a LIM-only protein which consists of four and a half LIM domains (Fimia et al., 
1999). The LIM domain is a cysteine-rich zinc-finger motif that is found in many 
proteins involved in the regulation of cellular processes via protein-protein 
interactions including gene expression, signal transduction, and cytoskeletal 
regulation (Review in Kadrmas and Becjerle, 2004). During spermatogenesis, ACT 
is initially present in the nucleus of round spermatids and translocates to the 
cytoplasm in elongated spermatids. The cytoplasmic localization of ACT is regulated 
by KIF17b, a testis-specific isoform of the brain kinesin2 motor protein KIF17 
(Kotaja et al., 2005). 
 
On tissue section of testis, I could show that endogenous ACT protein colocalizes 
with Lis1 in late spermatogenetic cells. BiFC assays in HeLa cells also revealed that 
the Lis1-ACT protein interaction occurs predominantly in the cytoplasm. Based on 
these results one may assume that the Lis1-ACT complex in elongated spermatids 
is also in the cytoplasm. Moreover, preliminary data show that overexpressed ACT 
in wild type MEFs distributes to the cytoplasm and to the nucleus, whereas in MEFs 
with reduced levels of Lis1 it predominantly goes to the nucleus (preliminary data 
not shown). These observations are compatible with the idea that Lis1 may function 
as a cytoplasmic retention protein for ACT. 
 
Previous studies demonstrated that the third LIM domain of ACT is required for 
association with CREM (Fima et al., 1999) and that all LIM domains of ACT are 
necessary for the interaction with KIF17b (Kotaja et al., 2005). I characterized the 
interaction between Lis1 and ACT and demonstrated that all LIM domains are 
required for the interaction with Lis1. The fact that ACT binding to both, Lis1 and 
KIF17b requires all LIM domains is interesting, because it raises the question 
whether or not both proteins can interact simultaneously with ACT or alternatively 
bind in a competitive manner.  
 
Formally, it can also not be ruled out that ACT functions as an adaptor protein 
between KIF17b and Lis1. While it is clear that ACT in association with KIF17b can 
be transported to the cytoplasm where it possibly also interacts with Lis1, a 
cytoplasmic function of ACT has not been identified yet and awaits further 
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investigation. 
 
The proteins of the kinesin superfamily (KIFs) are motor proteins that participate in 
various cellular functions, such as chromosomal and spindle movements during cell 
division, and transport of organelles and molecules (reviewed in Miki et al., 2001). 
Kinesin-1 is a motor protein for anterograde axonal transport. Lis1 forms a complex 
with cytoplasmic dynein and tubulins for migration towards the microtubule plus-
ends in a kinesin-1 dependent manner (Yamada et al., 2008). Interestingly, DISC1, 
a candidate gene for susceptibility to schizophrenia, interacts with KIF-1 that 
regulates the localization of Lis1 and NudeL in axons as a cargo receptor for axon 
elongation (Taya et al., 2007). KIF-17b associates with microtubules and mediates 
movement of organelles, vesicles, and proteins (reviewed in Monaco et al., 2004). 
Despite the structural links between Lis1, KIF-17b, and ACT the functional roles of 
these interactions in spermiogenesis remain to be discovered. 
 
 
Putative role of the Lis1 and BRAP complex 
 
The search for novel proteins that interact with Lis1 lead to the discovery of BRAP in 
the yeast two-hybrid screen. All isolated BRAP cDNA clones contained only coding 
sequence for the coiled-coil domain indicating that this part of BRAP is sufficient for 
the interaction with Lis1.  
 
BRAP is ubiquitously expressed and particularly enriched in testis (Li et al., 1998). 
Expression of BRAP overlaps with Lis1 in spermatogenic cells, however, little is 
known about BRAP function during spermatogenesis. 
 
BRAP was originally identified as a protein that specifically binds to the nuclear 
localization signal (NLS) motif of the breast cancer suppressor protein BRCA1 (Chen 
et al., 1996). BRAP protein is mainly found in the cytoplasm as previously shown 
with antibodies against BRAP and also in this study using HA or eGFP tagged BRAP 
(Asada et al., 2004; Li et al., 1998; Ozaki et al., 2009). Accordingly BRAP may 
regulate the translocation of nuclear proteins from the cytoplasm to the nucleus (Li 
et al., 1998).  
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The coiled-coil domain at the C-terminus of BRAP is sufficient to bind to the NLS 
motif of the cell cycle inhibitor p21 whereby it is maintained in the cytoplasm 
(Asada et al., 2004). I here demonstrated that the C-terminal coiled-coil domain is 
also sufficient for the interaction with Lis1. In contrast, the NLS motif of BRCA1 is 
recognized by the N-terminus of BRAP (Li et al., 1998) which is independently also 
able to bind to Lis1, in addition to the C-terminus. Thus, both domains of BRAP can 
mediate interaction with Lis1, and one can speculate that this may possibly occur in 
different cellular functions. 
 
Transport between the cytoplasm and nucleus is highly regulated by translocating 
shuttling carriers, such as importin and exportin complexes. Cytoplasmic retention 
proteins control nuclear transport through the identification of NLS sequences 
(reviewed in Cyert, 2001). For example, subcellular localization of NF-κB is 
determined by IκB (reviewed in Cyert, 2001). The NF-κB family of transcription 
factors contains highly conserved NLS motifs which directly cooperate with 
IκB/MAD-3 protein. Phosphorylated IκB is released from NF-κB and this allows 
nuclear translocation of NF-κB.  
 
Previous studies have demonstrated that BRAP interacts with Galectin-2, a member 
of galactose-binding lectins, which binds to tubulin and microtubules (Ozaki et al., 
2009). This observation might be related to a peculiar perinuclear localization of 
BRAP that seems to reflect part of the Golgi complex (Fig. 26). Since formation and 
positioning of Golgi vesicles occurs along microtubules and cytoplasmic dynein and 
Lis1 participate in this process (Harada et al., 1998; Smith et al., 2000), BRAP may 
also be recruited by Lis1 or galectin-2 to microtubules that functionally interact with 
the Golgi apparatus. This hypothesis, however awaits further investigations.  
 
BRAP has also been proposed to impede mitogenic signal propagation, referred to 
as IMP. The MAP kinase signaling pathway regulates a broad range of cellular 
responses, such as cell survival, cell division, proliferation, differentiation, and 
transformation. BRAP can play a role in the MAP kinase signal pathway acting as 
IMP (Matheny et al., 2004). The N-terminus of BRAP contains a putative RING-H2 
domain, common in ubiquitination, with Ras-responsive E3 ubiquitin ligase activity 
(Matheny et al., 2004). BRAP can be modified by auto-polyubiquitination depending 
on Ras activity. The Ring Finger domain in the predicted structure of BRAP is 
followed by a Znf-UBP, and a coiled-coil domain (SMART, smart.embl-heidelberg.de) 
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resembling the domain architecture of the RING B-box coiled-coil (RBCC) family of 
proteins (Jensen et al., 2001). The RBCC proteins are involved in various cellular 
processes including cell cycle regulation and apoptotic cell death. Mutations of 
RBCC have been found in many pathological conditions (reviewed in Meroni and 
Diez-Roux, 2005). 
 
 
Lis1 protein affects the dynamic organization of microtubules 
 
Lis1 is an essential factor for cell viability and represents an important microtubule 
associated protein (Sapir et al., 1997), that interacts through most (if not all) of its 
WD-40 repeat domains with tubulin (Caspi et al., 2003). By immunofluorescence 
analysis of the cytoskeleton of MEFs I find that microtubules in the absence of Lis1 
do not fully extend to the cell periphery and show decreased complexity of the 
microtubular network at the cell cortex, in good agreement with a recent report 
(Yingling et al, 2008). I also find that the level of acetylated tubulin is affected in 
Lis1-deficient cells suggesting that Lis1 might play a role for the stability of 
microtubules. Astral acetylated tubulin fibers are shortened and sparse and the 
level of acetylated tubulin protein is significantly decreased in cells deprived of Lis1. 
It is known that acetylation of -tubulin is a post-translational modification that can 
control microtubular dynamics, cytoskeletal remodeling, and cell motility (Creppe et 
al., 2009; Tran et al., 2007; Dompierre et al., 2007; Reed et al., 2006). Failure to 
acetylate the tubulin network possibly results in developmental brain defects 
including altered radial migration and aberrant neuronal branching (Creppe et al., 
2009). On the contrary, hyperacetylation of microtubule has been suggested to be 
associated with increased cell spreading (Tran et al., 2007). It also may provoke 
increased binding of motor proteins, such as kinesin-1 and cytoplasmic dynein, both 
proteins known to regulate bidirectional cargo transport (Dompierre et al., 2007; 
Reed et al., 2006).  
 
Interestingly, microtubules are highly stabilized in spermatid manchettes 
(Akhmanova et al., 2005) and Nayernia et al. (2003) confirmed that spermatid 
manchettes are tightly associated with Lis1. It would be of interest to examine the 
acetylation of tubulin in the manchette of spermatids from the homozygous gene 
trap mutant mouse to obtain additional insights into the involvement of Lis1 and 
microtubules during spermatogenesis.  
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In general, Lis1 regulates microtubular dynamics by affecting their catastrophe rate 
e.g. the transition from growth to shortening of microtubules (Sapir et al., 1997). 
According to this view, diminishing the cellular levels of Lis1 could cause the 
microtubular network to become instable and result in enhanced depolymerization 
rate of single fibers. In addition, Lis1 may also affect the cytoskeleton by 
influencing the plus-ends of microtubules. Microtubules show dynamic instability 
with constant transitions between phases of growth and shrinkage (Horio et al., 
1986). The tips of microtubules represent highly sensitive and important sites that 
directly control their growth (Yingling et al., 2008; reviewed in Kardon and Vale, 
2009). Microtubular polymerization generates a large number of binding sites for 
so-called plus-end binding proteins, which include EB1, CLIP-170, and CLIP-115. 
During microtubular growth these molecules disappear from the growing fiber and 
only transiently decorate a defined area at the tip of the tubular plus-end 
(Dragestein et al., 2008). The equilibrium between microtubules and plus-end 
binding proteins might be affected by post-translational modifications, 
conformational changes, and protein-protein interactions (Dragestein et al., 2008). 
 
Interestingly, in MEFs deprived of Lis1 I observed significantly augmented 
decoration by CLIP-115 at the tips of microtubules. A difference in plus-end 
accumulation of CLIP-170 was not detected. 
 
A possible explanation for this observation might be that in the absence of Lis1 
more CLIP-115 binding sites may be available at the plus-end tips of microtubules. 
Normally, Lis1 may facilitate the binding of specific factors to the microtubular tip-
end. When concentrations of Lis1 at the cell cortex are decreasing previously 
occupied sites can now become available for CLIP-115 to bind. Interestingly, it is 
known that CLIP-115 competes with other proteins, including CLIP-170, for 
microtubule plus-end binding sites (Hoogenraad et al., 2002). In addition, the 
dynactin complex, responsible for targeting cytoplasmic dynein to the microtubule 
plus-end, contains a subunit, termed p150glued, which is structurally related to the 
CLIP proteins (Lansbergen et al., 2004). It was shown previously that CLIP-115 
competes with both p150glued and Lis1 for binding to the zinc fingers at the C-
terminus of CLIP-170 (Lansbergen et al., 2004) and Lis1 is essential for localization 
of p150glued at the cell cortex (Smith et al., 2000). It is possible that lack of Lis1 
leads to a depletion of microtubule associated p150glued thereby allowing more CLIP-
115 at the growing microtubule plus-end. The association and dissociation of CLIP-
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115 with microtubules seems to be regulated by phosphorylation and 
dephosphorylation cycles (Rickard and Kreis, 1991). It is interesting to speculate 
that reduced levels of Lis1 may affect phosphorylation of CLIP-115, thereby 
changing the interaction with the microtubules. In the future, CLIP-115 
phosphorylation should be determined when the cellular levels of Lis1 are reduced. 
 
The rapid growth response to various environmental signals can influence the 
dynamic instability of microtubules (Sapir et al., 1997). I could show by live cell 
imaging of Lis1ΔLis1/ΔLis1 MEFs transfected with GFP-EB1 that the growth speed of 
microtubules at the plus-end was significantly reduced (as measured by GFP-EB1 
velocity). This data suggests that Lis1 regulates the microtubule dynamics by 
affecting microtubule growth speed. The direct cause of the slow velocity of growing 
microtubule ends in Lis1-deficient cells remains currently unclear, but it seems to be 
related to the comet tail length at the plus-end of microtubules. 
 
The microtubule plus-end decoration reflects the binding of plus-end tracking 
proteins to the growing end of microtubules. Hence, it is tempting to hypothesize 
that it might require more time to decorate the plus-end of microtubules in the 
absence of Lis1, measurable as a slow velocity of the growing microtubule. However 
these relationships need to be elucidated in detail in the future. 
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